1
|
Looijen AEM, van Mulligen E, Vonkeman HE, van der Helm-van Mil AHM, de Jong PHP. Responsiveness and sensitivity of PROMs to change in disease activity status in early and established rheumatoid arthritis. Rheumatology (Oxford) 2025; 64:1060-1067. [PMID: 38574380 PMCID: PMC11879326 DOI: 10.1093/rheumatology/keae213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2023] [Revised: 03/22/2024] [Accepted: 03/25/2024] [Indexed: 04/06/2024] Open
Abstract
OBJECTIVES To determine whether patient-reported outcome measures (PROMs) capturing activity limitations, health impact, pain, fatigue and work ability are responsive and sensitive to changes in disease activity status in patients with early and established RA. METHODS All early RA patients (n = 557) from the tREACH trial and established RA patients (n = 188) from the TARA trial were included. Both studies were multicentre, single-blinded trials with a treat-to-target management approach. The following PROMs were studied: HAQ Disability Index (HAQ-DI), morning stiffness severity, EQ-5D, general health, 36-item short form (SF-36), joint pain, fatigue and productivity loss. Mean changes in PROMs between two consecutive visits were compared with changes in disease activity status (remission, low disease activity and active disease) using linear mixed models and standardized response means. Additionally, the proportion of individual observations that showed an expected PROM response to disease activity status alterations was calculated. RESULTS HAQ-DI, morning stiffness severity, general health, EQ-5D and joint pain demonstrated responsiveness to improvement or worsening of disease activity status in both early and established RA. SF-36 physical and mental component scale, fatigue and productivity loss did not show this effect in both groups. Across nearly all PROMs, the magnitude of change and the proportion of individual observations that reflect a shift from and to active disease remained low. CONCLUSION HAQ-DI, morning stiffness severity, EQ-5D, general health and joint pain are responsive to disease activity status alterations on a group level in both early and established RA. For the individual patient the responsiveness of these PROMs is poor. CLINICAL TRIAL REGISTRATION tREACH trial (www.isrctn.com, ISRCTN26791028) and TARA trial (www.onderzoekmetmensen.nl, NTR2754).
Collapse
Affiliation(s)
| | - Elise van Mulligen
- Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands
- Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands
| | - Harald E Vonkeman
- Department of Rheumatology and Clinical Immunology, Medisch Spectrum Twente, Enschede, The Netherlands
- Department of Psychology, Health and Technology, University of Twente, Enschede, The Netherlands
| | - Annette H M van der Helm-van Mil
- Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands
- Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands
| | | |
Collapse
|
2
|
Gorial FI, Awadh NI, Humadi YA, Mutar MT, Hameed MM, Ali SB, Hasan HF, Aljafr AN. A 5 item version of the Workplace Activity Limitation Scale successfully identifies impaired work productivity in rheumatoid arthritis patients: A split-sample factor analysis approach. Int J Rheum Dis 2023; 26:501-509. [PMID: 36722751 DOI: 10.1111/1756-185x.14584] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2022] [Revised: 01/07/2023] [Accepted: 01/13/2023] [Indexed: 02/02/2023]
Abstract
BACKGROUND There is a growing interest in studying the effects of arthritis on a person's work productivity using a growing variety of outcome indicators. OBJECTIVES To develop a valid and reliable shortened version of the Workplace Activity Limitation Scale 12 (WALS-12) for assessing work productivity limitations in rheumatoid arthritis (RA) patients. METHODS A cross-sectional study involving 277 RA patients was conducted. An exploratory factor analysis on WALS-12 was used for item reduction on the first sample. Then confirmatory factor analysis (CFA) was run to establish the best fit indices of the reduced version. On the second sample, CFA and linear discriminant analysis were performed to assess the diagnostic performance and discriminant ability of the reduced form. A Bland-Altman method was used to find the agreement between the WALS-12 and the reduced one. RESULTS The WALS-12 was reduced to 5 items. The Cronbach α was 0.817, with a composite reliability of 0.715. The Spearman rho correlation coefficient ranged between 0.675 and 0.795 for WALS-5, which was higher for the scale items with their domains than the correlation of WALS-5 with the domains of Work Limitations Questionnaire-25. Also, the root square of the average variant extracted from WALS-5 was 0.802. WALS-5 showed excellent discriminant ability with an area under the curve of 0.98 (P < .001), sensitivity of 97%, specificity of 82%, and accuracy of 94%. The reduced version WALS-5 was in agreement with the original version WALS-12. CONCLUSIONS WALS-5 is a valid and reliable tool to assess the work productivity limitations in RA patients.
Collapse
Affiliation(s)
- Faiq I Gorial
- Rheumatology Unit, Department of Internal Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq
| | - Nabaa Ihsan Awadh
- Rheumatology Unit, Department of Internal Medicine, Baghdad Teaching Hospital, Baghdad, Iraq
| | - Yasameen Abbas Humadi
- Rheumatology Unit, Department of Internal Medicine, College of Medicine, Al-Nahrain University, Baghdad, Iraq
| | - Mohammed Tareq Mutar
- Department of Surgery, College of Medicine, University of Baghdad, Baghdad, Iraq
| | - Mustafa Majid Hameed
- Department of Internal Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq
| | - Shahlaa B Ali
- Rheumatology Unit, Department of Internal Medicine, Baghdad Teaching Hospital, Baghdad, Iraq
| | - Hala Fadhil Hasan
- Rheumatology Unit, Department of Internal Medicine, Baghdad Teaching Hospital, Baghdad, Iraq
| | - Alyaa N Aljafr
- Rheumatology Unit, Department of Internal Medicine, Baghdad Teaching Hospital, Baghdad, Iraq
| |
Collapse
|
3
|
Sharma S, Nilsson PM, Östergren PO, Häggman-Henrikson B, List T, Kallen MA. A New Instrument for Assessing Work-Related Body Mechanics and Strain in the General Population. THE JOURNAL OF PAIN 2023; 24:237-250. [PMID: 36216127 DOI: 10.1016/j.jpain.2022.09.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/05/2022] [Revised: 07/25/2022] [Accepted: 09/13/2022] [Indexed: 11/06/2022]
Abstract
Clinical pain is often linked to poor body mechanics, with individuals sometimes presenting multiple painful disorders. Such disorders may be influenced by behaviors that affect the general resiliency and health of the musculoskeletal system. We aimed to develop a self-reported scale using the Malmö Diet and Cancer Study questions on work-related body mechanical exposures. An expert panel identified 41 variables having content validity for musculoskeletal problems. Exploratory factor analysis was conducted on a random selection of 50% of the cohort (n = 6,789 adults); the remaining was reserved for confirmatory factor analyses (CFA), item response theory (IRT) item calibration, and differential item functioning investigations. Supported by standard measure development methods and fit criteria, the final unidimensional item bank contains 13 items. Overall CFA statistics (root mean square error of approximation = .09; comparative fit index = .96; Tucker-Lewis index = .96; standardized root mean residuals = .05) indicated excellent single-factor model fit and appropriateness of IRT modeling and calibration. Expert review and item information values (score-precision) guided selection of an 8-item short form with acceptable score-level reliabilities (≥.70) for T-scores = 39-80+. This measure provides reliable assessment of body mechanics strain in adults and can be useful when evaluating different contributions to musculoskeletal problems affecting pain-treatment success in future clinical research. PERSPECTIVE: This article presents the development and psychometric properties of a new measure, "Work-related Body Mechanics and Strain Scale (WR-BMSS)." The scale has 13-items or alternatively an 8-item short form. This measure could potentially help clinicians who seek to assess how musculoskeletal problems may contribute to patient pain and disability.
Collapse
Affiliation(s)
- Sonia Sharma
- Department of Neurosurgery, University of Rochester Medical Center, Rochester, New York; Department of Orofacial Pain and Jaw Function, Faculty of Odontology, Malmö University, Malmö, Sweden.
| | - Peter M Nilsson
- Department of Clinical Sciences, Research Group Internal Medicine - Epidemiology, Lund University, Skåne University Hospital, Malmö, Sweden; Strategic Research Area EpiHealth: Epidemiology for Health, Lund University, Lund, Sweden
| | - Per-Olof Östergren
- Strategic Research Area EpiHealth: Epidemiology for Health, Lund University, Lund, Sweden; Department of Clinical Sciences in Malmö, Division of Social Medicine and Global Health, Lund University, Lund, Sweden
| | - Birgitta Häggman-Henrikson
- Department of Orofacial Pain and Jaw Function, Faculty of Odontology, Malmö University, Malmö, Sweden; Department of Odontology, Clinical Oral Physiology, Faculty of Medicine, Umeå University, Umeå, Sweden
| | - Thomas List
- Department of Orofacial Pain and Jaw Function, Faculty of Odontology, Malmö University, Malmö, Sweden; Skåne University Hospital, Specialized Pain Rehabilitation, Lund, Sweden
| | - Michael A Kallen
- Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
| |
Collapse
|
4
|
Michaelis M, Rieger MA, Burgess S, Töws V, Abma FI, Bültmann U, Amick BC, Rothermund E. Evaluation of measurement properties of the German Work Role Functioning Questionnaire. BMC Public Health 2022; 22:1750. [PMID: 36109729 PMCID: PMC9479368 DOI: 10.1186/s12889-022-13893-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2022] [Accepted: 07/27/2022] [Indexed: 01/21/2023] Open
Abstract
OBJECTIVE We assessed the measurement properties of the German Work Role Functioning Questionnaire (WRFQ) after its cross-cultural adaptation of the Dutch version. The WRFQ is a generic role-specific instrument that measures how a particular health status influences the ability to meet work demands. METHODS We performed an observational study among German employees assessing the following measurement properties: 1) structural, 2) convergent and 3) discriminant validity, 4) floor and ceiling effects, 5) internal consistency, 6) reproducibility and 7) responsiveness. Participants were recruited from an online access panel sample aged 18 to 64 years having worked more than 12 hours in the last 4 weeks prior to study enrollment (n(T0) = 653, n(T1) = 66, n(T2) = 95). RESULTS Measurement properties proved to be good except for structural validity and responsiveness. An exploratory factor analysis showed limited replicability of three of the four original subscales. CONCLUSION With the WRFQ German version, the extent can be measured, to which employees with a certain health level experience problems can meet their work demands. This widely used health-related work outcome measurement tool, that helps to identify employees with decreasing work functioning, is now also available in German. This gives researchers and practitioners the opportunity to address work functioning in practice, e.g. in intervention studies in occupational health or rehabilitation. Further research to examine valid subscales is needed.
Collapse
Affiliation(s)
- Martina Michaelis
- grid.411544.10000 0001 0196 8249Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, Wilhelmstr. 27, 72074 Tübingen, Germany ,Research Centre for Occupational and Social Medicine (FFAS), Freiburg, Germany
| | - Monika A. Rieger
- grid.411544.10000 0001 0196 8249Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, Wilhelmstr. 27, 72074 Tübingen, Germany
| | - Stephanie Burgess
- grid.411544.10000 0001 0196 8249Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, Wilhelmstr. 27, 72074 Tübingen, Germany
| | - Viktoria Töws
- grid.410712.10000 0004 0473 882XDepartment of Psychosomatic Medicine and Psychotherapy, Ulm University Medical Center, Ulm, Germany
| | - Femke I. Abma
- grid.4494.d0000 0000 9558 4598Department of Health Sciences, University of Groningen, University Medical Center Groningen, Community and Occupational Medicine, Groningen, The Netherlands
| | - Ute Bültmann
- grid.4494.d0000 0000 9558 4598Department of Health Sciences, University of Groningen, University Medical Center Groningen, Community and Occupational Medicine, Groningen, The Netherlands
| | - Benjamin C. Amick
- grid.241054.60000 0004 4687 1637Fay W Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR USA
| | - Eva Rothermund
- grid.410712.10000 0004 0473 882XDepartment of Psychosomatic Medicine and Psychotherapy, Ulm University Medical Center, Ulm, Germany ,grid.6582.90000 0004 1936 9748Leadership Personality Centre Ulm (LPCU), Ulm University, Ulm, Germany
| |
Collapse
|
5
|
Shdaifat EA. Presenteeism and Productivity Loss Among Nurses. INTERNATIONAL JOURNAL OF OCCUPATIONAL SAFETY AND ERGONOMICS 2022:1-9. [PMID: 35912923 DOI: 10.1080/10803548.2022.2108660] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
Abstract
Objectives. Presenteeism is a significant problem among the working force and nurse is not an exception from these phenomena. The purpose of the study was to determine the productivity loss due to presenteeism from three dimensions and to evaluates the associated factors among nurses. Methods. A cross sectional study was conducted among 309 nurses to evaluate presenteeism using Stanford Presenteeism Scale (SPS), Health Performance Questionnaire (HPQ) and Work Productivity Short Inventory (WPSI). Results. The study found that nurses had a high level of presenteeism through using SPS (21.0 ± 4.3) and HPQ (80.0 ± 18.2). In Both scales, presenteeism was significantly associated with nurses who were older than 32 years, with an experience of more than 10 years, having children, and having two children. The results of WPSI showed that the productivity loss of presenteeism per nurse annually was 1,959 USD and for all nurses 605,283 USD. Conclusion. Eventually, evaluating the presenteeism level will help policymakers to understand the working conditions and related personal characteristics.
Collapse
Affiliation(s)
- Emad Adel Shdaifat
- Department of Community health nursing, College of Nursing, Imam Abdulrahman Bin Faisal University, P.O Box 1982, City Dammam, Saudi Arabia
| |
Collapse
|
6
|
Killip SC, MacDermid JC, Wouters RM, Sinden KE, Gewurtz RE, Selles RW, Packham TL. Rasch analysis of the brief Michigan Hand Questionnaire in patients with thumb osteoarthritis. BMC Musculoskelet Disord 2022; 23:551. [PMID: 35676667 PMCID: PMC9175463 DOI: 10.1186/s12891-022-05478-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/29/2022] [Accepted: 05/20/2022] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND The brief Michigan Hand Questionnaire (brief MHQ) is a 12-item self-reported measure of hand function for patients with hand disorders which has been validated using Classical Test Theory. Rasch analysis can provide more detailed psychometric information. The purpose of this Rasch analysis is to assess the psychometric properties of the brief MHQ for patients with thumb osteoarthritis, and to make recommendations for improvements to the questionnaire if needed. METHODS: The Michigan Hand Questionnaire and demographic data were collected from 923 thumb osteoarthritis patients treated in specialized clinics for hand surgery and therapy in the Netherlands. Rasch analysis was performed on the 12 items of the brief MHQ using RUMM 2030 to assess the fit of the brief MHQ to the Rasch model. To determine fit, analysis of fit summary statistics, individual person fit and individual item fit were assessed. Threshold distributions were assessed to identify if any items required rescoring. The Person Separation Index was calculated to measure reliability of the questionnaire. Differential item functioning was assessed to identify item bias, and Principal Component Analysis was performed to identify unidimensionality and local dependence. RESULTS The brief MHQ showed misfit (χ2 = 1312.5, p < 0.0001) with 6 items having disordered thresholds and 9 items requiring rescoring. After deleting 3 of the rescored items due to significant item fit residuals, the brief MHQ had an acceptable reliability (Cronbach's alpha = 0.79). Misfit to the model (χ2 = 49.6, p = 0.0001), multidimensionality (10.2% of t-tests were significant), and item bias from non-uniform differential item functioning for 7 items across many person variables were still found. CONCLUSION Although no satisfactory solutions were found to correct the misfit to the Rasch model, it is recommended that the response options of the brief MHQ be rescored, and that items 6, 9 and 10 be removed. The lack of unidimensionality indicates that the items do not represent the singular construct of hand disability and that totalling the scores of the brief MHQ does not provide a valid measure of hand disability for people with thumb osteoarthritis. The 37-item Michigan Hand Questionnaire may provide a better assessment of hand disability for patients with thumb osteoarthritis.
Collapse
Affiliation(s)
- Shannon C Killip
- School of Rehabilitation Science, McMaster University, 1400 Main Street West IAHS 403, Hamilton, ON, L8S 4L8, Canada.
| | - Joy C MacDermid
- School of Rehabilitation Science, McMaster University, 1400 Main Street West IAHS 403, Hamilton, ON, L8S 4L8, Canada.,Physical Therapy and Surgery, Western University, London, ON, Canada.,Clinical Research Lab, Hand and Upper Limb Centre, St. Joseph's Health Centre, London, ON, Canada
| | - Robbert M Wouters
- Departments of Rehabilitation Medicine and Plastic, Reconstructive and Hand Surgery, Erasmus MC Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.,Center for Hand Therapy, Handtherapie Nederland, Eindhoven, The Netherlands
| | - Kathryn E Sinden
- School of Kinesiology, Lakehead University, 955 Oliver Rd, Thunder Bay, Thunder Bay, ON, P7B 5E1, Canada
| | - Rebecca E Gewurtz
- School of Rehabilitation Science, McMaster University, 1400 Main Street West IAHS 403, Hamilton, ON, L8S 4L8, Canada
| | - Ruud W Selles
- Departments of Rehabilitation Medicine and Plastic, Reconstructive and Hand Surgery, Erasmus MC Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands
| | - Tara L Packham
- School of Rehabilitation Science, McMaster University, 1400 Main Street West IAHS 403, Hamilton, ON, L8S 4L8, Canada
| |
Collapse
|
7
|
Fontana MA, Islam W, Richardson MA, Medina CK, Kohilakis EC, Qureshi SA, MacLean CH. Presenteeism and absenteeism before and after single-level lumbar spine surgery. Spine J 2022; 22:776-786. [PMID: 34706279 PMCID: PMC9035193 DOI: 10.1016/j.spinee.2021.10.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/15/2021] [Revised: 10/05/2021] [Accepted: 10/19/2021] [Indexed: 02/03/2023]
Abstract
BACKGROUND CONTEXT Health can impact work performance through absenteeism, time spent away from work, and presenteeism, inhibited at-work performance. Low back pain is common and costly, both in terms of direct medical expenditures and indirect reduced work performance. PURPOSE Surgery for lumbar spinal pathology is an important part of treatment for patients who do not respond to nonsurgical management. While the indirect costs of return to work and absenteeism among employed patients undergoing lumbar spine surgery have been studied, little work has been done to quantify presenteeism before and after lumbar spine surgery. STUDY DESIGN/SETTING Prospective cohort study at a single high-volume urban musculoskeletal specialty hospital. PATIENT SAMPLE Patients undergoing single-level lumbar spinal fusion and/or decompression surgery. OUTCOME MEASURES Presenteeism and absenteeism were measured using the World Health Organization's Health and Work Performance Questionnaire before surgery, as well as 6 weeks, 6 months, and 12 months after surgery. METHODS Average presenteeism and absenteeism were evaluated at pre-surgical baseline and each follow-up timepoint. Monthly average time lost to presenteeism and absenteeism were calculated before surgery and 12 months after surgery. Study data were collected and managed using REDCap electronic data capture tools with support from Clinical and Translational Science Center grant, UL1TR002384. One author discloses royalties, private investments, consulting fees, speaking/teaching arrangements, travel, board of directorship, and scientific advisory board membership totaling >$300,000. RESULTS We enrolled 134 employed surgical patients, among whom 115 (86%) responded at 6 weeks, 105 (78%) responded at 6 months, and 115 (86%) responded at 12 months. Preoperatively, mean age was 56.4 years (median 57.5), and 41.0% were women; 68 (50.7%) had only decompressions, while 66 (49.3%) had fusions. Among respondents at each time point, 98%, 92%, and 92% were still employed, among whom 76%, 96%, and 96% had resumed working, respectively (median 29 days). Average at-work performance among working patients (who responded at each pair of timepoints) moved from 75.4 to 78.7 between baseline and 6 weeks, 71.8 to 85.9 between baseline and 6 months, and 73.0 to 88.1 between baseline and 12 months. Gains were concentrated among the 52.0% of patients whose at-work performance was declining (and low) leading up to surgery. Average absenteeism was relatively unmoved between baseline and each follow-up. Before surgery, the monthly average time lost to presenteeism and absenteeism was 19.8% and 18.9%, respectively; 12 months after surgery, these numbers were 9.7% and 16.0%; changes represent a mitigated loss of 13.0 percentage points of average monthly value. CONCLUSIONS Presenteeism and absenteeism contributed roughly evenly to preoperative average monthly lost time. Although average changes in absenteeism and 6-week at-work performance were small, average changes in at-work performance at 6 and 12 months were significant. Cost-benefit analyses of lumbar spine surgery should therefore consider improved presenteeism, which appears to offset some of the direct and indirect costs of surgical treatment.
Collapse
Affiliation(s)
- Mark Alan Fontana
- Center for Analytics, Modeling, and Performance, Hospital for Special Surgery, New York, NY, USA; Center for the Advancement of Value in Musculoskeletal Care, Hospital for Special Surgery, New York, NY, USA; Department of Population Health Sciences, Weill Cornell Medical College, New York, NY, USA.
| | - Wasif Islam
- Center for the Advancement of Value in Musculoskeletal Care, Hospital for Special Surgery, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA
| | - Michelle A Richardson
- Center for the Advancement of Value in Musculoskeletal Care, Hospital for Special Surgery, New York, NY, USA; University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
| | - Cathlyn K Medina
- Center for the Advancement of Value in Musculoskeletal Care, Hospital for Special Surgery, New York, NY, USA; Duke University School of Medicine, Durham, NC, USA
| | - Eleni C Kohilakis
- Center for the Advancement of Value in Musculoskeletal Care, Hospital for Special Surgery, New York, NY, USA
| | - Sheeraz A Qureshi
- Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, USA
| | - Catherine H MacLean
- Center for the Advancement of Value in Musculoskeletal Care, Hospital for Special Surgery, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA
| |
Collapse
|
8
|
Alavinia SM, Jetha A, Hitzig SL, McCauley D, Routhier F, Noonan VK, Linassi G, Farahani F, Omidvar M, Jeyathevan G, Craven BC. Development of employment indicators to advance the quality of spinal cord injury rehabilitation care: SCI-High Project. J Spinal Cord Med 2021; 44:S118-S133. [PMID: 34779730 PMCID: PMC8604534 DOI: 10.1080/10790268.2021.1955205] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
CONTEXT Employment and Return to Work (RTW) rates following spinal cord injury/disease (SCI/D) are low due to individual and impairments characteristics, secondary health conditions, social and environmental barriers, prior work experience, workplace supports and resources, and physical or psychosocial work demands. To improve RTW, the SCI-High Project team developed a set of Employment structure, process, and outcome indicators for adults with SCI/D in the first 18 months after rehabilitation admission. METHODS A pan-Canadian Working Group of diverse stakeholders: (1) defined the Employment construct; (2) conducted a systematic search of available outcomes measures; (3) constructed a Driver diagram summarizing factors associated with employment. Subsequent facilitated meetings allowed for the creation of structure and process indicators, and the selection of outcome indicators. RESULTS The structure indicator is the proportion of SCI/D rehabilitation programs with an employment resource center. The process indicator is the proportion of SCI/D rehabilitation inpatients who receive an employment assessment during inpatient rehabilitation. The intermediary and final outcome measures are the Readiness for Return-to-Work Scale (RRTW) and Work Productivity and Activity Impairment (WPAI). Scale A of the RRTW for those who are unemployed and Scale B of RRTW and WPAI will be used for those who are employed. CONCLUSION This framework of Employment indicators intends to support the RTW needs of persons with SCI/D by ensuring that rehabilitation professionals provide opportunities to explore RTW within the first 18 months after rehab admission. Increased employment rates have the potential to enhance the wellbeing, health, and longevity of individuals with SCI/D.
Collapse
Affiliation(s)
- Seyed Mohammad Alavinia
- KITE Research Institute, Toronto Rehabilitation Institute – University Health Network, Toronto, Ontario, Canada
| | - Arif Jetha
- Institute for Work & Health, Toronto, Ontario, Canada,Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
| | - Sander L. Hitzig
- St. John’s Rehab Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada,Department of Occupational Science and Occupational Therapy, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada,Rehabilitation Sciences Institute, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
| | | | - François Routhier
- Department of Rehabilitation, Faculty of Medicine, Université Laval, Québec, Québec, Canada,Centre for interdisciplinary research in rehabilitation and social integration, Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale, Québec, Québec, Canada
| | | | - Gary Linassi
- Department of Physical Medicine and Rehabilitation, College of Medicine University of Saskatchewan, Saskatoon, Saskatchewan, Canada
| | - Farnoosh Farahani
- KITE Research Institute, Toronto Rehabilitation Institute – University Health Network, Toronto, Ontario, Canada
| | - Maryam Omidvar
- KITE Research Institute, Toronto Rehabilitation Institute – University Health Network, Toronto, Ontario, Canada
| | - Gaya Jeyathevan
- KITE Research Institute, Toronto Rehabilitation Institute – University Health Network, Toronto, Ontario, Canada
| | - B. Catharine Craven
- KITE Research Institute, Toronto Rehabilitation Institute – University Health Network, Toronto, Ontario, Canada,Division of Physical Medicine and Rehabilitation, Department of Medicine, University of Toronto, Toronto, Ontario, Canada,Brain and Spinal Cord Rehabilitation Program, Toronto Rehabilitation Institute – University Health Network, Toronto, Ontario, Canada,Correspondence to: B. Catharine Craven, KITE Research Institute, Toronto Rehabilitation Institute, University Health Network, 206-H 520 Sutherland Drive, Toronto, ONM4G3V9, Canada; Ph: 416-597-3422x6122.
| |
Collapse
|
9
|
Oliveira SAD, Campos JADB, Marôco J, Marziale MHP, Rocha FLR. Psychometric properties of the Work Limitations Questionnaire applied to nursing workers. Rev Lat Am Enfermagem 2021; 29:e3466. [PMID: 34468623 PMCID: PMC8432506 DOI: 10.1590/1518-8345.4771.3466] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2020] [Accepted: 01/05/2021] [Indexed: 11/21/2022] Open
Abstract
OBJECTIVE to evaluate the psychometric properties of the Work Limitations Questionnaire and to measure presenteeism in a sample of nursing workers. METHOD a cross-sectional study, with non-probabilistic sampling. Data was collected between July 2018 and February 2019 in two high-complexity hospitals, and the sample was composed of 304 participants. The validity analysis of the Work Limitations Questionnaire was performed by means of Confirmatory Factor Analysis. RESULTS most of the participants were women (88.5%), with a mean age of 40.9 years old. The validities of the factorial, convergent and discriminant construct and the reliability of the complete version and of the 16-item version of the instrument were adequate after adjusting the models to the sample. A statistically significant and negative correlation (p<0.001) was verified between the workload, working time and the Time Management and Physical Demands dimensions; as well as a statistically significant (p<0.001) correlation between working time and the Mental-Interpersonal Demands and Production Demands dimensions. Gender and professional category did not influence presenteeism. The rate of loss of productivity at work was 19.51%. CONCLUSION the Work Limitations Questionnaire showed adequate validity and reliability and can be considered a valid and reliable instrument for assessing presenteeism in the nursing team.
Collapse
Affiliation(s)
- Samuel Andrade de Oliveira
- Universidade de São Paulo, Escola de Enfermagem de Ribeirão Preto, PAHO/WHO Collaborating Centre for Nursing Research Development, Ribeirão Preto, SP, Brazil.,Scholarship holder at the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil
| | | | - João Marôco
- Instituto Universitário de Ciências Psicológicas, Sociais e da Vida, Lisboa, PT, Portugal
| | - Maria Helena Palucci Marziale
- Universidade de São Paulo, Escola de Enfermagem de Ribeirão Preto, PAHO/WHO Collaborating Centre for Nursing Research Development, Ribeirão Preto, SP, Brazil
| | - Fernanda Ludmilla Rossi Rocha
- Universidade de São Paulo, Escola de Enfermagem de Ribeirão Preto, PAHO/WHO Collaborating Centre for Nursing Research Development, Ribeirão Preto, SP, Brazil
| |
Collapse
|
10
|
Abstract
BACKGROUND Rheumatoid arthritis is often associated with work disability, a term used to describe the inability to be or to remain employed. Work disability is a common implication of rheumatoid arthritis. OBJECTIVE This review aims to identify and analyze the predictive factors of work disability among patients with rheumatoid arthritis, as well as to group these factors into broader categories, based on the most current studies in this field. METHODS An electronic search was conducted using Google Scholar, MEDLINE and PsycINFO databases. Eighty-six international journal articles were finally selected. RESULTS The results suggest that occupational, personal, medical and societal factors are the main predictive categories of work disability for people with rheumatoid arthritis. CONCLUSIONS Medical progress has had a positive effect on the development and the rates of work disability among patients with RA. Work disability is, however, not only defined by medical factors. Occupational, personal and societal factors interact with each other and affect the development of work disability in RA. The results of this review emphasize the need for medical and vocational therapy interventions, social support and state policies that target the work status of patients with RA. Future holistic research approaches to the field are required for a complete picture and concrete solutions with the aim of keeping patients with RA employed.
Collapse
Affiliation(s)
- Doxa Papakonstantinou
- Department of Educational and Social Policy, University of Macedonia, 156 Egnatia street, 54636, Thessaloniki, Greece. Tel.: +30 2310 891403; E-mail: ; ORCID: https://orcid.org/0000-0002-3242-7629
| |
Collapse
|
11
|
Fontana MA, Islam W, Richardson MA, Medina CK, McLawhorn AS, MacLean CH. Presenteeism and Absenteeism Before and After Total Hip and Knee Arthroplasty. J Arthroplasty 2021; 36:1511-1519.e5. [PMID: 33358309 PMCID: PMC8152113 DOI: 10.1016/j.arth.2020.11.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/03/2020] [Revised: 11/11/2020] [Accepted: 11/13/2020] [Indexed: 02/02/2023] Open
Abstract
BACKGROUND Absenteeism is costly, yet evidence suggests that presenteeism-illness-related reduced productivity at work-is costlier. We quantified employed patients' presenteeism and absenteeism before and after total joint arthroplasty (TJA). METHODS We measured presenteeism (0-100 scale, 100 full performance) and absenteeism using the World Health Organization's Health and Work Performance Questionnaire before and after TJA among a convenience sample of employed patients. We captured detailed information about employment and job characteristics and evaluated how and among whom presenteeism and absenteeism improved. RESULTS In total, 636 primary, unilateral TJA patients responded to an enrollment email, confirmed employment, and completed a preoperative survey (mean age: 62.1 years, 55.3% women). Full at-work performance was reported by 19.7%. Among 520 (81.8%) who responded to a 1-year follow-up, 473 (91.0%) were still employed, and 461 (88.7%) had resumed working. Among patients reporting at baseline and 1 year, average at-work performance improved from 80.7 to 89.4. A Wilcoxon signed-rank test indicated that postoperative performance was significantly higher than preoperative performance (P < .0001). The percentage of patients who reported full at-work performance increased from 20.9% to 36.8% (delta = 15.9%, 95% confidence interval = [10.0%, 21.9%], P < .0001). Presenteeism gains were concentrated among patients who reported declining work performance leading up to surgery. Average changes in absences were relatively small. Combined, the average monthly value lost by employers to presenteeism declined from 15.3% to 8.3% and to absenteeism from 16.9% to 15.5% (ie, mitigated loss of 8.4% of monthly value). CONCLUSION Among employed patients before TJA, presenteeism and absenteeism were similarly costly. After, employed patients reported increased performance, concentrated among those with declining performance leading up to surgery.
Collapse
Affiliation(s)
- Mark Alan Fontana
- Center for the Advancement of Value in Musculoskeletal Care, Hospital for Special Surgery, New York, NY, USA,Department of Population Health Sciences, New York, NY, USA
| | - Wasif Islam
- Center for the Advancement of Value in Musculoskeletal Care, Hospital for Special Surgery, New York, NY, USA,Weill Cornell Medical College, New York, NY, USA
| | - Michelle A. Richardson
- Center for the Advancement of Value in Musculoskeletal Care, Hospital for Special Surgery, New York, NY, USA,University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
| | - Cathlyn K. Medina
- Center for the Advancement of Value in Musculoskeletal Care, Hospital for Special Surgery, New York, NY, USA
| | - Alexander S. McLawhorn
- Center for the Advancement of Value in Musculoskeletal Care, Hospital for Special Surgery, New York, NY, USA,Department of Orthopedics, Hospital for Special Surgery, New York, NY, USA
| | - Catherine H. MacLean
- Center for the Advancement of Value in Musculoskeletal Care, Hospital for Special Surgery, New York, NY, USA,Department of Medicine, Weill Cornell Medical College, New York, NY, USA
| |
Collapse
|
12
|
Kemp JL, Johnston RTR, Coburn SL, Jones DM, Schache AG, Mentiplay BF, King MG, Scholes MJ, De Oliveira Silva D, Smith A, McPhail SM, Crossley KM. Physiotherapist-led treatment for femoroacetabular impingement syndrome (the PhysioFIRST study): a protocol for a participant and assessor-blinded randomised controlled trial. BMJ Open 2021; 11:e041742. [PMID: 33827828 PMCID: PMC8031040 DOI: 10.1136/bmjopen-2020-041742] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
INTRODUCTION This double-blind, randomised controlled trial (RCT) aims to estimate the effect of a physiotherapist-led intervention with targeted strengthening compared with a physiotherapist-led intervention with standardised stretching, on hip-related quality of life (QOL) or perceived improvement at 6 months in people with femoroacetabular impingement (FAI) syndrome. We hypothesise that at 6 months, targeted strengthening physiotherapist-led treatment will be associated with greater improvements in hip-related QOL or greater patient-perceived global improvement when compared with standardised stretching physiotherapist-led treatment. METHODS AND ANALYSIS We will recruit 164 participants with FAI syndrome who will be randomised into one of the two intervention groups, both receiving one-on-one treatment with the physiotherapist over 6 months. The targeted strengthening physiotherapist-led treatment group will receive a personalised exercise therapy and education programme. The standardised stretching physiotherapist-led treatment group will receive standardised stretching and personalised education programme. Primary outcomes are change in hip-related QOL using International Hip Outcome Tool-33 and patient-perceived global improvement. Secondary outcomes include cost-effectiveness, muscle strength, range of motion, functional task performance, biomechanics, hip cartilage structure and physical activity levels. Statistical analyses will make comparisons between both treatment groups by intention to treat, with all randomised participants included in analyses, regardless of protocol adherence. Linear mixed models (with baseline value as a covariate and treatment condition as a fixed factor) will be used to evaluate the treatment effect and 95% CI at primary end-point (6 months). ETHICS AND DISSEMINATION The study protocol was approved (La Trobe University Human Ethics Committee (HEC17-080)) and prospectively registered with the Australian New Zealand Clinical Trials Registry. The findings of this RCT will be disseminated through peer reviewed scientific journals and conferences. Patients were involved in study development and will receive a short summary following the completion of the RCT. TRIAL REGISTRATION NUMBER ACTRN12617001350314.
Collapse
Affiliation(s)
- Joanne L Kemp
- La Trobe Sport and Exercise Medicine Research Centre, La Trobe University, Bundoora, Victoria, Australia
| | - Richard T R Johnston
- La Trobe Sport and Exercise Medicine Research Centre, La Trobe University, Bundoora, Victoria, Australia
| | - Sally L Coburn
- La Trobe Sport and Exercise Medicine Research Centre, La Trobe University, Bundoora, Victoria, Australia
| | - Denise M Jones
- La Trobe Sport and Exercise Medicine Research Centre, La Trobe University, Bundoora, Victoria, Australia
| | - Anthony G Schache
- La Trobe Sport and Exercise Medicine Research Centre, La Trobe University, Bundoora, Victoria, Australia
| | - Benjamin F Mentiplay
- La Trobe Sport and Exercise Medicine Research Centre, La Trobe University, Bundoora, Victoria, Australia
| | - Matthew G King
- La Trobe Sport and Exercise Medicine Research Centre, La Trobe University, Bundoora, Victoria, Australia
| | - Mark J Scholes
- La Trobe Sport and Exercise Medicine Research Centre, La Trobe University, Bundoora, Victoria, Australia
| | - Danilo De Oliveira Silva
- La Trobe Sport and Exercise Medicine Research Centre, La Trobe University, Bundoora, Victoria, Australia
| | - Anne Smith
- School of Allied Health, Curtin University, Perth, Western Australia, Australia
| | - Steven M McPhail
- Australian Centre for Health Service Innovation and Centre for Healthcare Transformation, and School of Public Health & Social Work, Queensland University of Technology, Kelvin Grove, Queensland, Australia
- Clinical Informatics Directorate, Metro South Health, Brisbane, Queensland, Australia
| | - Kay M Crossley
- La Trobe Sport and Exercise Medicine Research Centre, La Trobe University, Bundoora, Victoria, Australia
| |
Collapse
|
13
|
Muramatsu K, Nakao K, Ide H, Furui Y. Testing the Construct Validity and Responsiveness of the Single-Item Presenteeism Question. J Occup Environ Med 2021; 63:e187-e196. [PMID: 33596024 DOI: 10.1097/jom.0000000000002158] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
OBJECTIVE We tested the construct validity and responsiveness of a single-item instrument for measuring absolute presenteeism-the single-item presenteeism question (SPQ). METHODS Two self-report questionnaire surveys were conducted among employees of 24 small- or medium-sized companies (N = 1021) concerning the recognized predictors of presenteeism-absenteeism, subjective health risks, work engagement, and workplace social capital. Responsiveness was measured by determining whether changes in the presence of predictors between the surveys were accompanied by commensurate changes in SPQ presenteeism. RESULTS SPQ presenteeism exhibited significant associations with the predictors, denoting adequate construct validity. Regarding responsiveness, unfavorable changes in most predictors were associated with increased SPQ presenteeism, as expected. CONCLUSIONS We confirmed the construct validity and responsiveness of the SPQ-an instrument that can be employed to promote workplace health and productivity management.
Collapse
Affiliation(s)
- Kenji Muramatsu
- Institute for Future Initiatives, The University of Tokyo, Tokyo, Japan
| | | | | | | |
Collapse
|
14
|
Jetha A, Johnson SR, Gignac MAM. Unmet Workplace Support Needs and Lost Productivity of Workers With Systemic Sclerosis: A Path Analysis Study. Arthritis Care Res (Hoboken) 2021; 73:423-431. [DOI: 10.1002/acr.24123] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2019] [Accepted: 12/10/2019] [Indexed: 11/12/2022]
Affiliation(s)
- Arif Jetha
- Institute for Work and Health and Dalla Lana School of Public Health University of Toronto Toronto Ontario Canada
| | - Sindhu R. Johnson
- Toronto Scleroderma Program Toronto Western Hospital Mount Sinai Hospital, and University of Toronto Toronto Ontario Canada
| | - Monique A. M. Gignac
- Institute for Work and Health and Dalla Lana School of Public Health University of Toronto Toronto Ontario Canada
| |
Collapse
|
15
|
Hammond A, Sutton C, Cotterill S, Woodbridge S, O'Brien R, Radford K, Forshaw D, Verstappen S, Jones C, Marsden A, Eden M, Prior Y, Culley J, Holland P, Walker-Bone K, Hough Y, O'Neill TW, Ching A, Parker J. The effect on work presenteeism of job retention vocational rehabilitation compared to a written self-help work advice pack for employed people with inflammatory arthritis: protocol for a multi-centre randomised controlled trial (the WORKWELL trial). BMC Musculoskelet Disord 2020; 21:607. [PMID: 32912199 PMCID: PMC7488441 DOI: 10.1186/s12891-020-03619-1] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/03/2020] [Accepted: 08/31/2020] [Indexed: 01/01/2023] Open
Abstract
Background Work problems are common in people with inflammatory arthritis. Up to 50% stop work within 10 years due to their condition and up to 67% report presenteeism (i.e. reduced work productivity), even amongst those with low disease activity. Job retention vocational rehabilitation (JRVR) may help prevent or postpone job loss and reduce presenteeism through work assessment, work-related rehabilitation and enabling job accommodations. This aims to create a better match between the person’s abilities and their job demands. The objectives of the Workwell trial are to test the overall effectiveness and cost-effectiveness of JRVR (WORKWELL) provided by additionally trained National Health Service (NHS) occupational therapists compared to a control group who receive self-help information both in addition to usual care. Methods Based on the learning from a feasibility trial (the WORK-IA trial: ISRCTN76777720), the WORKWELL trial is a multi-centre, pragmatic, individually-randomised parallel group superiority trial, including economic evaluation, contextual factors analysis and process evaluation. Two hundred forty employed adults with rheumatoid arthritis, undifferentiated inflammatory arthritis or psoriatic arthritis (in secondary care), aged 18 years or older with work instability will be randomised to one of two groups: a self-help written work advice pack plus usual care (control intervention); or WORKWELL JRVR plus a self-help written work advice pack and usual care. WORKWELL will be delivered by occupational therapists provided with additional JRVR training from the research team. The primary outcome is presenteeism as measured using the Work Limitations Questionnaire-25. A comprehensive range of secondary outcomes of work, health, contextual factors and health resource use are included. Outcomes are measured at 6- and 12- months (with 12-months as the primary end-point). A multi-perspective within-trial cost-effectiveness analyses will also be conducted. Discussion This trial will contribute to the evidence base for provision of JRVR to people with inflammatory arthritis. If JRVR is found to be effective in enabling people to keep working, the findings will support decision-making about provision of JRVR by rheumatology teams, therapy services and healthcare commissioners, and providing evidence of the effectiveness of JRVR and the economic impact of its implementation. Trial registration Clinical Trials.Gov: NCT03942783. Registered 08/05/2019 (https://clinicaltrials.gov/ct2/show/NCT03942783); ISRCTN Registry: ISRCTN61762297. Registered:13/05/2019 (http://www.isrctn.com/ISRCTN61762297). Retrospectively registered.
Collapse
Affiliation(s)
- Alison Hammond
- Centre for Health Sciences Research, University of Salford, Allerton L701, Frederick Road, Salford, Greater Manchester, M6 6PU, UK.
| | - Chris Sutton
- Centre for Biostatistics, Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK
| | - Sarah Cotterill
- Centre for Biostatistics, Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK
| | - Sarah Woodbridge
- Centre for Health Sciences Research, University of Salford, Allerton L701, Frederick Road, Salford, Greater Manchester, M6 6PU, UK
| | - Rachel O'Brien
- School of Health and Wellbeing, Sheffield Hallam University, Sheffield, UK
| | - Kate Radford
- Division of Rehabilitation and Ageing, University of Nottingham, Nottingham, UK
| | - Denise Forshaw
- Lancashire Clinical Trials Unit, University of Central Lancashire, Brook Building, Preston, Lancashire, UK
| | - Suzanne Verstappen
- Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.,NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
| | - Cheryl Jones
- Manchester Centre for Health Economics, Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK
| | - Antonia Marsden
- Centre for Biostatistics, Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK
| | - Martin Eden
- Manchester Centre for Health Economics, Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK
| | - Yeliz Prior
- Centre for Health Sciences Research, University of Salford, Allerton L701, Frederick Road, Salford, Greater Manchester, M6 6PU, UK
| | | | - Paula Holland
- Division of Health Research, Lancaster University, Lancaster, UK
| | - Karen Walker-Bone
- MRC Versus Arthritis Centre for Musculoskeletal Health and Work, University of Southampton, Southampton, UK
| | - Yvonne Hough
- Rheumatology/ Occupational Therapy, St Helens and Knowsley Teaching Hospitals NHS Foundation Trust, St Helens Hospital, St Helens, Merseyside, UK
| | - Terence W O'Neill
- Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.,NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK
| | - Angela Ching
- Centre for Health Sciences Research, University of Salford, Allerton L701, Frederick Road, Salford, Greater Manchester, M6 6PU, UK
| | - Jennifer Parker
- Centre for Health Sciences Research, University of Salford, Allerton L701, Frederick Road, Salford, Greater Manchester, M6 6PU, UK
| |
Collapse
|
16
|
Hollick RJ, Stelfox K, Dean LE, Shim J, Walker-Bone K, Macfarlane GJ. Outcomes and treatment responses, including work productivity, among people with axial spondyloarthritis living in urban and rural areas: a mixed-methods study within a national register. Ann Rheum Dis 2020; 79:1055-1062. [PMID: 32522742 PMCID: PMC7392479 DOI: 10.1136/annrheumdis-2020-216988] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2020] [Revised: 05/08/2020] [Accepted: 05/12/2020] [Indexed: 11/26/2022]
Abstract
OBJECTIVE To examine differences in clinical and patient-reported outcomes, including work, in individuals with axial spondyloarthritis (axSpA) living in rural and urban settings. METHODS Using a sequential, explanatory mixed-method design, data from the British Society for Rheumatology Biologics Register for Ankylosing Spondylitis were used to (1) characterise participants with axSpA living in rural and urban areas and (b) assess any differences in outcome after commencement of biologic therapy (phase 1). Semistructured interviews (phase 2) further explored the results from phase 1. RESULTS Patients with axSpA living in rural areas were older and more likely to work in a physical job. Among patients prescribed biologics, there were no differences in response to biologics, but after adjustment for age, sex and local area deprivation rural dwellers reported more presenteeism and overall work impairment. Work effects could be explained by accounting for individual differences in disease activity, fatigue, physical function and job type. Interviews highlighted the complex relationship between clinical factors, contextual factors (work environment, job demands) and work disability. The ability to work and flexibility in terms of what, when and how tasks are undertaken were important. Support from employers was variable and healthcare professionals were often perceived as unsupportive. CONCLUSIONS Patients with axSpA living in rural areas report a greater impact of their disease on work productivity. New measures are needed to capture important contextual factors and comprehensively determine the impact of long-term conditions on work. Future European League Against Rheumatism axSpA recommendations should include support to work as a target to optimise quality of life in patients with axSpA.
Collapse
Affiliation(s)
- Rosemary J Hollick
- Aberdeen Centre for Arthritis and Musculoskeletal Health, Epidemiology Group, University of Aberdeen, Aberdeen, UK
- MRC Versus Arthritis Centre for Musculoskeletal Health and Work, University of Aberdeen, Aberdeen, UK
- Epidemiology Group, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK
| | - Kevin Stelfox
- Aberdeen Centre for Arthritis and Musculoskeletal Health, Epidemiology Group, University of Aberdeen, Aberdeen, UK
- MRC Versus Arthritis Centre for Musculoskeletal Health and Work, University of Aberdeen, Aberdeen, UK
- Epidemiology Group, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK
| | - Linda E Dean
- Aberdeen Centre for Arthritis and Musculoskeletal Health, Epidemiology Group, University of Aberdeen, Aberdeen, UK
- MRC Versus Arthritis Centre for Musculoskeletal Health and Work, University of Aberdeen, Aberdeen, UK
- Epidemiology Group, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK
| | - Joanna Shim
- Aberdeen Centre for Arthritis and Musculoskeletal Health, Epidemiology Group, University of Aberdeen, Aberdeen, UK
- MRC Versus Arthritis Centre for Musculoskeletal Health and Work, University of Aberdeen, Aberdeen, UK
- Epidemiology Group, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK
| | - Karen Walker-Bone
- MRC Versus Arthritis Centre for Musculoskeletal Health and Work, University of Southampton, Southampton, UK
| | - Gary J Macfarlane
- Aberdeen Centre for Arthritis and Musculoskeletal Health, Epidemiology Group, University of Aberdeen, Aberdeen, UK
- MRC Versus Arthritis Centre for Musculoskeletal Health and Work, University of Aberdeen, Aberdeen, UK
- Epidemiology Group, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK
| |
Collapse
|
17
|
Improvements in Workplace Productivity in Working Patients With Major Depressive Disorder: Results From the AtWoRC Study. J Occup Environ Med 2020; 62:e94-e101. [PMID: 31895735 DOI: 10.1097/jom.0000000000001805] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVE To assess changes in workplace productivity and functioning in an open-label study in working patients receiving vortioxetine (10 to 20 mg/d) for major depressive disorder (MDD). METHODS Associations between items in the Work Limitations Questionnaire (WLQ), the Sheehan Disability Scale (SDS), and the Work Productivity and Activity Impairment (WPAI) questionnaire were assessed at 12 and 52 weeks by Pearson correlation coefficients. RESULTS Significant improvements were observed across all domains of workplace productivity and functioning after 12 and 52 weeks' vortioxetine treatment. Strong correlations were seen between improvements in WLQ mental domains and WPAI presenteeism and SDS work/school items. Presenteeism showed stronger correlations with other workplace productivity measures than absenteeism. CONCLUSIONS Presenteeism and absenteeism impact productivity in working patients with MDD. Vortioxetine confers long-term benefits across all workplace functioning domains.
Collapse
|
18
|
Ruhle SA, Breitsohl H, Aboagye E, Baba V, Biron C, Correia Leal C, Dietz C, Ferreira AI, Gerich J, Johns G, Karanika-Murray M, Lohaus D, Løkke A, Lopes SL, Martinez LF, Miraglia M, Muschalla B, Poethke U, Sarwat N, Schade H, Steidelmüller C, Vinberg S, Whysall Z, Yang T. “To work, or not to work, that is the question” – Recent trends and avenues for research on presenteeism. EUROPEAN JOURNAL OF WORK AND ORGANIZATIONAL PSYCHOLOGY 2019. [DOI: 10.1080/1359432x.2019.1704734] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- S. A. Ruhle
- Faculty of Business Administration and Economics, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
| | - H. Breitsohl
- Human Resources, Leadership, and Organization, University of Klagenfurt, Klagenfurt, Austria
| | - E. Aboagye
- Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden
| | - V. Baba
- DeGroote School of Business, McMaster University, Hamilton, Canada
| | - C. Biron
- Department of Management, Laval University, Québec, Canada
| | - C. Correia Leal
- Business Research Unit (BRU-IUL), Instituto Universitário de Lisboa (ISCTE-IUL), Lisbon, Portugal
| | - C. Dietz
- Faculty of Life Sciences, Leipzig University, Leipzig, Germany
| | - A. I. Ferreira
- Business Research Unit (BRU-IUL), Instituto Universitário de Lisboa (ISCTE-IUL), Lisbon, Portugal
| | - J. Gerich
- Institute for Sociology, Johannes Kepler Universitat Linz, Linz, Austria
| | - G. Johns
- John Molson School of Business, Concordia University, Montreal, Canada
- Sauder School of Business, University of British Columbia, Vancouver, Canada
| | | | - D. Lohaus
- Department of Business Psychology, University of Applied SciencesDarmstadt, Darmstadt, Germany
| | - A. Løkke
- Department of Management, Aarhus University, Aarhus, Denmark
| | - S. L. Lopes
- Business Research Unit (BRU-IUL), Instituto Universitário de Lisboa (ISCTE-IUL), Lisbon, Portugal
| | - L. F. Martinez
- Nova School of Business and Economics, Universidade Nova de Lisboa, Carcavelos, Portugal
| | - M. Miraglia
- University of Liverpool Management School, University of Liverpool, Liverpool, UK
| | - B. Muschalla
- Technische Universität Braunschweig, Braunschweig, Germany
| | - U. Poethke
- Center for Higher Education, TU Dortmund University, Dortmund, Germany
| | - N. Sarwat
- Institute of Management Sciences, Bahauddin Zakariya University, Multan, Pakistan
| | - H. Schade
- Department of Psychology, Chemnitz University of Technology, Chemnitz, Germany
| | - C. Steidelmüller
- Federal Institute for Occupational Safety and Health, Dortmund, Germany
| | - S. Vinberg
- Department of Health Sciences, Mid Sweden University, Sundsvall, Sweden
| | - Z. Whysall
- Nottingham Business School, Nottingham Trent University, Nottingham, UK
| | - T. Yang
- Faculty of Organization and Human Resource, Beijing Institute of Technology, Beijing, China
| |
Collapse
|
19
|
Munk R, Storheim K, Småstuen MC, Grotle M. Measuring Productivity Costs in Patients With Musculoskeletal Disorders: Measurement Properties of the Institute for Medical Technology Assessment Productivity Cost Questionnaire. VALUE IN HEALTH : THE JOURNAL OF THE INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH 2019; 22:1410-1416. [PMID: 31806198 DOI: 10.1016/j.jval.2019.07.011] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/08/2019] [Revised: 05/21/2019] [Accepted: 07/17/2019] [Indexed: 06/10/2023]
Abstract
BACKGROUND The Institute for Medical Technology Assessment Productivity Cost Questionnaire (iPCQ) was recently developed to cover all domains of productivity costs; absenteeism, presenteeism and productivity costs related to unpaid work. The original iPCQ has not been tested with respect to neither content or construct validity, nor reliability, and there is no Norwegian version of the questionnaire. OBJECTIVES To translate and cross-culturally adapt the iPCQ into Norwegian and to test its measurement properties among patients with musculoskeletal disorders. METHODS Translation and cross-cultural adaptation was conducted according to guidelines, and measurement properties were investigated using a cross-sectional design including a test-retest assessment. Patients with musculoskeletal disorders were recruited from secondary care. Data quality, content validity (10 patients evaluated comprehensibility, 2 researchers and 1 clinician evaluated relevance and comprehensiveness), construct validity (factor analysis, internal consistency, divergent hypothesis testing), and test-retest reliability (intraclass correlation coefficient two-way random average agreement, Cohen's unweighted kappa) were assessed. RESULTS In total, 115 patients with a mean age (SD) of 46 (9) years were included, and 62 responded to the retest. The questionnaire was feasible, with little missing data and no floor or ceiling effects. Content validity displayed good comprehensibility and relevance and sufficient comprehensiveness. Factor analysis revealed a 3-component solution accounting for 82% of the total variance; items loaded as expected and supported the original structure of the iPCQ. Internal consistency was acceptable for the 3 components of productivity cost, with an inter-item correlation ranging from 0.42 to 0.62. Further, a total of 91% of our hypotheses were verified. The intraclass correlation coefficient values ranged from 0.88 to 0.99 for all items except one; kappa ranged from 0.61 to 0.92, indicating overall good reliability of the questionnaire. CONCLUSIONS The Norwegian iPCQ showed good measurement properties among patients with musculoskeletal disorders from secondary care in Norway. We therefore recommend the iPCQ as a useful tool for measuring productivity costs in patients with musculoskeletal disorders.
Collapse
Affiliation(s)
- Rikke Munk
- Department of Physiotherapy, Oslo Metropolitan University, Oslo, Norway.
| | - Kjersti Storheim
- Department of Physiotherapy, Oslo Metropolitan University, Oslo, Norway; Division of Clinical Neuroscience, Research and Communication Unit for Musculoskeletal Health, Oslo University Hospital, Oslo, Norway
| | - Milada C Småstuen
- Department of Physiotherapy, Oslo Metropolitan University, Oslo, Norway
| | - Margreth Grotle
- Department of Physiotherapy, Oslo Metropolitan University, Oslo, Norway; Division of Clinical Neuroscience, Research and Communication Unit for Musculoskeletal Health, Oslo University Hospital, Oslo, Norway
| |
Collapse
|
20
|
Xavier RM, Zerbini CAF, Pollak DF, Morales-Torres JLA, Chalem P, Restrepo JFM, Duhau JA, Amado JR, Abello M, de la Vega MC, Dávila AP, Biegun PM, Arruda MS, Ramos-Remus C. Burden of rheumatoid arthritis on patients' work productivity and quality of life. Adv Rheumatol 2019; 59:47. [PMID: 31706348 DOI: 10.1186/s42358-019-0090-8] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2018] [Accepted: 10/21/2019] [Indexed: 02/08/2023] Open
Abstract
BACKGROUND To determine the burden of Rheumatoid Arthritis (RA) on patients' work productivity and health related quality of life (HRQoL), and examine the influence of several exposure variables; to analyze the progression of RA over 1 year and its impact on work productivity and HRQoL. METHODS International multicenter prospective survey including patients in 18 centers in Argentina, Brazil, Colombia and Mexico with diagnosis of RA and aged between 21-55 years. The following standard questionnaires were completed at baseline and throughout a 1-year follow-up: WPAI:RA, WALS, WLQ-25, EQ-5D-3 L and SF-36. Clinical and demographic variables were also collected through interview. RESULTS The study enrolled 290 patients on baseline visit. Overall mean scores at baseline visit were: WPAI:RA (presenteeism) = 29.5% (SD = 28.8%); WPAI:RA (absenteeism) = 9.0% (SD = 23.2%); WPAI:RA (absenteeism and presenteeism) = 8.6% (SD = 22.6%); WALS = 9.0 (SD = 6.1); WLQ-25 = 7.0% (SD = 5.1%); SF-36 Physical Scale = 39.1 (SD = 10.3) and Mental Scale = 45.4 (SD = 11.3); EQ-5D-3 L VAS = 69.8 (SD = 20.4) and EQ-5D-3 L index = 0.67 (SD = 0.23). Higher educational levels were associated with better results in WLQ-25, while previous orthopedic surgeries reduced absenteeism results of WPAI:RA and work limitations in WLQ-25. Higher disease duration was associated with decreased HRQoL. Intensification of disease activity was associated with decreased work productivity and HRQoL, except in WLQ-25. In the longitudinal analysis, worsening in disease activity was associated with a decrease in both work productivity and HRQoL. CONCLUSIONS RA patients are dealing with workplace disabilities and limitations and loss in HRQoL, and multiple factors seems to be associated with this. Worsening of disease activity further decreased work productivity and HRQoL, stressing the importance of disease tight control.
Collapse
Affiliation(s)
- Ricardo Machado Xavier
- Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
| | | | | | | | - Philippe Chalem
- Fundación Instituto de Reumatología Fernando Chalem, Bogotá, Colombia
| | | | - Javier Arnaldo Duhau
- Centro de Investigaciones en Enfermedades Reumáticas (CIER), Buenos Aires, Argentina
| | | | | | | | | | | | | | - Cesar Ramos-Remus
- Unidad de Investigación en Enf. Crónico-Degenerativas, Guadalajara, Mexico
| |
Collapse
|
21
|
Job Satisfaction Mediates the Association between Perceived Disability and Work Productivity in Migraine Headache Patients. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2019; 16:ijerph16183341. [PMID: 31510071 PMCID: PMC6765904 DOI: 10.3390/ijerph16183341] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/25/2019] [Revised: 08/17/2019] [Accepted: 09/05/2019] [Indexed: 12/15/2022]
Abstract
Migraine headache is the cause of an estimated 250,000,000 lost days from work or school every year and is often associated with decreased work productivity. The aim of this cross-sectional study was to assess the relationship between perceived disability, job satisfaction and work productivity in patients affected by chronic migraineurs. Participants were 98 consecutive adult outpatients admitted to the Regional Referral Headache Centre of the Sant’Andrea Hospital in Rome, Italy. Patients were administered the Italian Perceived Disability Scale, The Quality of Life Enjoyment and Satisfaction Questionnaire–Work Subscale and The Endicott Work Productivity Scale. Perceived disability is significantly associated with job satisfaction and work productivity. Job satisfaction is significantly related to work productivity and mediates the association between perceived disability and work productivity in patients affected by chronic migraineurs. Our results confirm that patients suffering from migraine headaches who have negative perceptions of their disability are less satisfied with their job, which in turn, decreases their work productivity.
Collapse
|
22
|
Beemster TT, van Velzen JM, van Bennekom CAM, Reneman MF, Frings-Dresen MHW. Test-Retest Reliability, Agreement and Responsiveness of Productivity Loss (iPCQ-VR) and Healthcare Utilization (TiCP-VR) Questionnaires for Sick Workers with Chronic Musculoskeletal Pain. JOURNAL OF OCCUPATIONAL REHABILITATION 2019; 29:91-103. [PMID: 29549605 DOI: 10.1007/s10926-018-9767-9] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
The purpose of this study was to assess test-retest reliability, agreement, and responsiveness of questionnaires on productivity loss (iPCQ-VR) and healthcare utilization (TiCP-VR) for sick-listed workers with chronic musculoskeletal pain who were referred to vocational rehabilitation. Methods Test-retest reliability and agreement was assessed with a 2-week interval. Responsiveness was assessed at discharge after a 15-week vocational rehabilitation (VR) program. Data was obtained from six Dutch VR centers. Test-retest reliability was determined with intraclass correlation coefficient (ICC) and Cohen's kappa. Agreement was determined by Standard Error of Measurement (SEM), smallest detectable changes (on group and individual level), and percentage observed, positive and negative agreement. Responsiveness was determined with area under the curve (AUC) obtained from receiver operation characteristic (ROC). Results A sample of 52 participants on test-retest reliability and agreement, and a sample of 223 on responsiveness were included in the analysis. Productivity loss (iPCQ-VR): ICCs ranged from 0.52 to 0.90, kappa ranged from 0.42 to 0.96, and AUC ranged from 0.55 to 0.86. Healthcare utilization (TiCP-VR): ICC was 0.81, and kappa values of the single healthcare utilization items ranged from 0.11 to 1.00. Conclusions The iPCQ-VR showed good measurement properties on working status, number of hours working per week and long-term sick leave, and low measurement properties on short-term sick leave and presenteeism. The TiCP-VR showed adequate reliability on all healthcare utilization items together and medication use, but showed low measurement properties on the single healthcare utilization items.
Collapse
Affiliation(s)
- Timo T Beemster
- Department of Rehabilitation Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
- Department of Research and Development, Heliomare Rehabilitation Center, Wijk aan Zee, The Netherlands.
- Academic Medical Center, Department Coronel Institute of Occupational Health, Amsterdam Public Health Research Institute, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
| | - Judith M van Velzen
- Department of Research and Development, Heliomare Rehabilitation Center, Wijk aan Zee, The Netherlands
- Academic Medical Center, Department Coronel Institute of Occupational Health, Amsterdam Public Health Research Institute, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands
| | - Coen A M van Bennekom
- Department of Research and Development, Heliomare Rehabilitation Center, Wijk aan Zee, The Netherlands
- Academic Medical Center, Department Coronel Institute of Occupational Health, Amsterdam Public Health Research Institute, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands
| | - Michiel F Reneman
- Department of Rehabilitation Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - Monique H W Frings-Dresen
- Academic Medical Center, Department Coronel Institute of Occupational Health, Amsterdam Public Health Research Institute, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands
| |
Collapse
|
23
|
MacDermid JC, Tang K, Sinden KE, D'Amico R. Work Functioning Among Firefighters: A Comparison Between Self-Reported Limitations and Functional Task Performance. JOURNAL OF OCCUPATIONAL REHABILITATION 2019; 29:194-204. [PMID: 29802581 DOI: 10.1007/s10926-018-9778-6] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Purpose Performance-based and disease indicators have been widely studied in firefighters; self-reported work role limitations have not. The aim of this study was to describe the distributions and correlations of a generic self-reported Work Limitations Questionnaire (WLQ-26) and firefighting-specific task performance-based tests. Methods Active firefighters from the City of Hamilton Fire Services (n = 293) were recruited. Participants completed the WLQ-26 to quantify on-the-job difficulties over five work domains: work scheduling (4 items), output demands (7 items), physical demands (8 items), mental demands (4 items), and social demands (3 items). A subset of participants (n = 149) were also assessed on hose drag and stair climb with a high-rise pack performance-based tests. Descriptive statistics and correlations were used to compare item/subscale performance; and to describe the inter-relationships between tests. Results The mean WLQ-26 item scores (/5) ranged from 4.1 to 4.4 (median = 5 for all items); most firefighters (54.5-80.5%) selected "difficult none of the time" response option on all items. A substantial ceiling effect was observed across all five WLQ-26 subscales as 44.0-55.6% were in the highest category. Subscale means ranged from 61.8 (social demands) to 78.7 (output demands and physical demands). Internal consistency exceeded 0.90 on all subscales. For the hose drag task, the mean time-to-completion was 48.0 s (SD = 14.5; range 20.4-95.0). For the stair climb task, the mean time-to-completion was 76.7 s (SD = 37.2; range 21.0-218.0). There were no significant correlations between self-report work limitations and performance of firefighting tasks. Conclusions The WLQ-26 measured five domains, but had ceiling effects in firefighters. Performance-based testing showed wider score range, lacked ceiling effects and did not correlate to the WLQ-26. A firefighter-specific, self-report role functioning scale may be needed to identify compromised work role capabilities in firefighters.
Collapse
Affiliation(s)
- Joy C MacDermid
- Physical Therapy and Surgery, Western University, London, ON, Canada.
- Clinical Research Lab, Hand and Upper Limb Centre, St. Joseph's Health Centre, London, ON, Canada.
| | - Kenneth Tang
- Clinical Research Unit, CHEO Research Institute, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada
| | - Kathryn E Sinden
- School of Kinesiology, Lakehead University, Thunder Bay, ON, Canada
| | - Robert D'Amico
- Hamilton Professional Fire Fighters Association, Hamilton, ON, Canada
| |
Collapse
|
24
|
Retirement Expectations of Older Workers with Arthritis and Diabetes Compared with Those of Workers with No Chronic Diseases. Can J Aging 2019; 38:296-314. [DOI: 10.1017/s0714980818000685] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
RÉSUMÉLes plans de retraite des adultes atteints de maladies chroniques sont peu connus. Dans le cadre de cette étude, des travailleurs canadiens âgés de 50 à 67 ans provenant d’un regroupement national de 80 000 personnes (arthrite, n = 631 ; diabète, n = 286 ; arthrite et diabète, n = 111 ; aucune maladie chronique invalidante, n = 538) ont participé à une enquête transversale sur ce sujet. Les questions posées aux participants traitaient de l’âge prévu pour leur départ à la retraite, de leurs plans de travail futurs, de la possibilité d’un départ hâtif à la retraite et de la transition vers la retraite. Des analyses de khi-carré, de variance et des régressions ont permis d’évaluer les attentes et les facteurs qui y étaient associés. Les travailleurs souffrant d’arthrite et de diabète avaient des plans de retraite semblables à ceux des participants sains, malgré leurs problèmes de santé, et ces plans concordaient avec les attentes associées au fait de travailler jusqu’à un âge de retraite conventionnel. Toutefois, le nombre de répondants souffrant d’arthrite ou de diabète qui avaient prévu une retraite anticipée était plus élevé que celui des participants en bonne santé. Contrairement aux prévisions, la part de la variance associée aux facteurs liés à la santé était moindre que celle des autres facteurs en ce qui concerne les attentes en matière de retraite. Ces résultats mettent en lumière la complexité des attentes liées à la retraite et soulignent l’importance de l’adéquation personne-travail, malgré la présence de maladies.
Collapse
|
25
|
|
26
|
Gignac MAM, Kristman V, Smith PM, Beaton DE, Badley EM, Ibrahim S, Mustard CA, Wang M. Are There Differences in Workplace Accommodation Needs, Use and Unmet Needs Among Older Workers With Arthritis, Diabetes and No Chronic Conditions? Examining the Role of Health and Work Context. WORK, AGING AND RETIREMENT 2018; 4:381-398. [PMID: 30288294 PMCID: PMC6159000 DOI: 10.1093/workar/way004] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
The aging of workforces combined with the prevalence of age-related chronic diseases has generated interest in whether large numbers of older workers will need workplace accommodations. This research applied work functioning theory to examine accommodation availability, need and use in workers with arthritis, diabetes, or no chronic disabling diseases; factors associated with accommodation needs; and the relationship of accommodation needs met, unmet or exceeded to job outcomes. Participants were aged 50-67 years, employed, and had arthritis (n = 631), diabetes (n = 286), both arthritis/diabetes (n = 111) or no chronic disabling conditions (healthy controls n = 538). They were recruited from a national panel of 80,000 individuals and a cross-sectional survey was administered online or by telephone. Questionnaires assessed demographics, health, work context, workplace accommodations, and job outcomes. Chi-square analyses, analyses of variance, and regression analyses compared groups. Respondents were similar in many demographic and work context factors. As expected, workers with arthritis and/or diabetes often reported poorer health and employment outcomes. Yet, there were few differences across health conditions in need for or use of accommodations with most participants reporting accommodations needs met. In keeping with work functioning theory, unmet accommodation needs were largely related to work context, not health. Workers whose accommodation needs were exceeded reported better job outcomes than those with accommodation needs met. Findings highlight both work context and health in understanding workplace accommodations and suggest that many older workers can meet accommodation needs with existing workplace practices. However, additional research aimed at workplace support and the timing of accommodation use is needed.
Collapse
Affiliation(s)
- Monique A M Gignac
- Institute for Work & Health, Toronto, Ontario, Canada
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
- Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada
| | - Vicki Kristman
- Institute for Work & Health, Toronto, Ontario, Canada
- Department of Health Sciences, Lakehead University, Thunder Bay, Ontario, Canada
| | - Peter M Smith
- Institute for Work & Health, Toronto, Ontario, Canada
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| | - Dorcas E Beaton
- Institute for Work & Health, Toronto, Ontario, Canada
- Mobility Program Clinical Research Unit, St. Michael’s Hospital, Toronto, Ontario, Canada
- Department of Occupational Science and Occupational Therapy, University of Toronto, Toronto, Ontario, Canada
| | - Elizabeth M Badley
- Institute for Work & Health, Toronto, Ontario, Canada
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
- Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada
| | | | - Cameron A Mustard
- Institute for Work & Health, Toronto, Ontario, Canada
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
| | | |
Collapse
|
27
|
Workability for persons with chronic diseases. A systematic review of validity and utility of assessments in German language / Valide und praktikable deutschsprachige Assessments zur Erfassung der Arbeitsfähigkeit bei Menschen mit chronischen Erkrankungen – eine systematische Review. INTERNATIONAL JOURNAL OF HEALTH PROFESSIONS 2018. [DOI: 10.2478/ijhp-2018-0008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
Abstract
Abstract
Background
People with chronic diseases are often limited in their workability. Evaluating and enabling workability is central in rehabilitation. The aim of this study was to evaluate validity and utility of workability assessments in German for persons with chronic diseases.
Methods
The study is a systematic review. First, we systematically searched for literature in the databases Medline, CINAHL, PsycInfo, Cochrane HTA Database, DARE, CCMed, Sowiport, and BASE using following keywords: evaluation tool, chronic disease, workability, validity, and utility. Then, we evaluated the content and the quality of the studies based on criteria and decided if they were included.
Results
In total, validity and utility of eight workability assessments are described based on 74 studies. The assessments are: Productivity Costs Questionnaire (iPCQ), Work Instability Scale for Rheumatoid Arthritis (RA-WIS), Screening-Instrument Arbeit und Beruf (SIBAR), Screening-Instrument zur Feststellung des Bedarfs an medizinisch-beruflich orientierten Maßnahmen in der medizinischen Rehabilitation (SIMBO), Valuation of Lost Productivity Questionnaire (VOLP), Work Ability Index (WAI/ABI), Work Limitations Questionnaire (WLQ), and Work Productivity and Activity Impairment Questionnaire (WPAI).
Conclusion
The results revealed the availability of eight workability assessments for persons with chronic diseases in German language. They have strengths and weaknesses in relation to the construct, purpose, application, and evidence base. These could be the base for choice of an assessment. Overall, we suggest using workability assessment in order to meet the legal requirements for the use of standardized assessments and the increasing demand to establish evidence of the effectiveness of interventions.
Collapse
|
28
|
Measuring work functioning in individuals with musculoskeletal disorders with reference to the International Classification of Functioning, Disability, and Health: a systematic literature review. Int J Rehabil Res 2018; 41:97-109. [PMID: 29608459 DOI: 10.1097/mrr.0000000000000283] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
29
|
Makishima M, Fujino Y, Kubo T, Izumi H, Uehara M, Oyama I, Matsuda S. Validity and responsiveness of the work functioning impairment scale (WFun) in workers with pain due to musculoskeletal disorders. J Occup Health 2018; 60:156-162. [PMID: 29311438 PMCID: PMC5886883 DOI: 10.1539/joh.17-0166-oa] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Objective: To determine the convergent validity and responsiveness of the work functioning impairment scale (WFun) in workers with musculoskeletal disorder-related pain. Methods: Participants were extracted from an internet user study and prospectively examined using the pain intensity numerical rating scale (pain-NRS), the work ability numerical rating scale (productivity-NRS), and the WFun at baseline, 2 weeks, 6 weeks, and 3 months. The convergent validity and responsiveness of the WFun were examined by multilevel regression analysis. Results: A total of 786 workers participated and 593 completed all surveys. The WFun score gradually increased and decreased as the pain-NRS and the productivity-NRS increased, respectively. Changes in the WFun score steadily increased and decreased as changes in the pain-NRS and the productivity-NRS increased, respectively. Multilevel analyses showed that all linear associations were significant. Conclusions: The convergent validity and responsiveness of the WFun were consistent with the expected direction and magnitude.
Collapse
Affiliation(s)
- Misako Makishima
- Department of Preventive Medicine and Community Health, University of Occupational and Environmental Health.,Department of Medical Affairs, Chugai Pharmaceutical Co., Ltd
| | - Yoshihisa Fujino
- Department of Environmental Epidemiology, University of Occupational and Environmental Health
| | - Tatsuhiko Kubo
- Department of Preventive Medicine and Community Health, University of Occupational and Environmental Health
| | - Hiroyuki Izumi
- Department of Ergonomics, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health
| | | | | | - Shinya Matsuda
- Department of Preventive Medicine and Community Health, University of Occupational and Environmental Health
| |
Collapse
|
30
|
Purc-Stephenson RJ, Dostie J, Smith HJ. Swimming Against the Current: A Qualitative Review of the Work Experiences and Adaptations Made by Employees With Arthritis. Arthritis Care Res (Hoboken) 2018; 70:1587-1597. [PMID: 29381840 DOI: 10.1002/acr.23528] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2017] [Accepted: 01/23/2018] [Indexed: 11/11/2022]
Abstract
OBJECTIVE To describe the experiences and strategies of employees with arthritis to maintain employment, and to use this information to build a conceptual model. METHODS We conducted a systematic review of qualitative studies that examined the work experiences of employees with arthritis. Published studies on arthritis and employment were searched from electronic databases (1980-2017) and bibliographic reviews of relevant studies. We used meta-ethnography to synthesize the findings. RESULTS We reviewed 17 studies that reported on the experiences of 873 employees. We identified 11 main themes that highlight common issues experienced by employees with arthritis and grouped these into 4 higher-order categories: changing nature of the disease (emotional issues, cognitive struggles, unpredictable physical symptoms), intrapersonal issues (personal meaning of work, preserving a work identity), interpersonal issues (managing disclosure, gaining coworker support, organizational culture issues), and work-sustainability strategies (making personal adjustments, using social support, using workplace accommodations). Using these themes, we developed the Job Sustainability Model to illustrate how disease, personal, and work-related factors interact to influence what type of coping behaviors are used and when. Initially, employees with arthritis rely on making personal adjustments, using social support, and medical intervention. However, when these coping behaviors fail to be effective, they draw upon workplace accommodations and resources. CONCLUSION Arthritis disrupts an employee's work life by impairing his or her capacity to be a productive worker. Our results highlight how employees with arthritis make strategic adaptations to maintain a productive work life for as long as possible. The findings of this study have implications for work-related interventions aimed at preserving employment.
Collapse
|
31
|
Rai KK, Adab P, Ayres JG, Siebert WS, Sadhra SS, Sitch AJ, Fitzmaurice DA, Jordan RE. Factors associated with work productivity among people with COPD: Birmingham COPD Cohort. Occup Environ Med 2017; 74:859-867. [PMID: 28899966 DOI: 10.1136/oemed-2016-104014] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2016] [Revised: 03/30/2017] [Accepted: 05/17/2017] [Indexed: 11/04/2022]
Abstract
BACKGROUND Patients with chronic obstructive pulmonary disease (COPD) are more likely to take time off work (absenteeism) and report poor performance at work (presenteeism) compared to those without COPD. Little is known about the modifiable factors associated with these work productivity outcomes. AIM To assess the factors associated with work productivity among COPD patients. METHODS Cross-sectional analysis of baseline data from a subsample (those in paid employment) of the Birmingham COPD Cohort study. Absenteeism was defined by self-report over the previous 12 months. Presenteeism was assessed using the Stanford Presenteeism Scale. Logistic regression analysis was used to assess the effects of sociodemographic, clinical and occupational characteristics on work productivity. RESULTS Among 348 included participants, increasing dyspnoea was the only factor associated with both absenteeism and presenteeism (p for trend<0.01). Additionally, increasing history of occupational exposure to vapours, gases, dusts or fumes (VGDF) was independently associated with presenteeism (p for trend<0.01). CONCLUSIONS This is the first study to identify important factors associated with poor work productivity among patients with COPD. Future studies should evaluate interventions aimed at managing breathlessness and reducing occupational exposures to VGDF on work productivity among patients with COPD.
Collapse
Affiliation(s)
- Kiran K Rai
- Institute of Applied Health Research, University of Birmingham, Birmingham, UK
| | - Peymané Adab
- Institute of Applied Health Research, University of Birmingham, Birmingham, UK
| | - Jon G Ayres
- Institute of Clinical Sciences, University of Birmingham, Birmingham, UK
| | - W Stanley Siebert
- The Department of Business and Labour Economics, The University of Birmingham, Birmingham, UK
| | - Steven S Sadhra
- Institute of Clinical Sciences, University of Birmingham, Birmingham, UK
| | - Alice J Sitch
- Institute of Applied Health Research, University of Birmingham, Birmingham, UK
| | - David A Fitzmaurice
- Institute of Applied Health Research, University of Birmingham, Birmingham, UK
| | - Rachel E Jordan
- Institute of Applied Health Research, University of Birmingham, Birmingham, UK
| | | |
Collapse
|
32
|
Hammond A, O’Brien R, Woodbridge S, Bradshaw L, Prior Y, Radford K, Culley J, Whitham D, Ruth Pulikottil-Jacob. Job retention vocational rehabilitation for employed people with inflammatory arthritis (WORK-IA): a feasibility randomized controlled trial. BMC Musculoskelet Disord 2017; 18:315. [PMID: 28732491 PMCID: PMC5521067 DOI: 10.1186/s12891-017-1671-5] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/09/2017] [Accepted: 07/12/2017] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Inflammatory arthritis leads to work disability, absenteeism and presenteeism (i.e. at-work productivity loss) at high cost to individuals, employers and society. A trial of job retention vocational rehabilitation (VR) in the United States identified this helped people keep working. The effectiveness of this VR in countries with different socioeconomic policies and conditions, and its impact on absenteeism, presenteeism and health, are unknown. This feasibility study tested the acceptability of this VR, modified for the United Kingdom, compared to written advice about managing work problems. To help plan a randomized controlled trial, we tested screening, recruitment, intervention delivery, response rates, applicability of the control intervention and identified the relevant primary outcome. METHODS A feasibility randomized controlled trial with rheumatoid, psoriatic or inflammatory arthritis patients randomized to receive either job retention VR or written information only (the WORK-IA trial). Following three days VR training, rheumatology occupational therapists provided individualised VR on a one to one basis. VR included work assessment, activity diaries and action planning, and (as applicable) arthritis self-management in the workplace, ergonomics, fatigue and stress management, orthoses, employment rights and support services, assistive technology, work modifications, psychological and disclosure support, workplace visits and employer liaison. RESULTS Fifty five (10%) people were recruited from 539 screened. Follow-up response rates were acceptable at 80%. VR was delivered with fidelity. VR was more acceptable than written advice only (7.8 versus 6.7). VR took on average 4 h at a cost of £135 per person. Outcome assessment indicated VR was better than written advice in reducing presenteeism (Work Limitations Questionnaire (WLQ) change score mean: VR = -12.4 (SD 13.2); control = -2.5 (SD 15.9), absenteeism, perceived risk of job loss and improving pain and health status, indicating proof of concept. The preferred primary outcome measure was the WLQ, a presenteeism measure. CONCLUSIONS This brief job retention VR is a credible and acceptable intervention for people with inflammatory arthritis with concerns about continuing to work due to arthritis. TRIAL REGISTRATION ISRCTN 76777720 . Registered 21.9.12.
Collapse
Affiliation(s)
- Alison Hammond
- Centre for Health Sciences Research (OT), L701 Allerton, University of Salford, Frederick Road, Salford, M6 6PU UK
| | - Rachel O’Brien
- Centre for Health and Social Care Research, Sheffield Hallam University, Montgomery House, 32 Collegiate Crescent, Sheffield, S10 2BP UK
| | | | - Lucy Bradshaw
- Nottingham Clinical Trials Unit, Queens Medical Centre, University of Nottingham, NG7 2UHL, Nottingham, UK
| | - Yeliz Prior
- Centre for Health Sciences Research (OT), L701 Allerton, University of Salford, Frederick Road, Salford, M6 6PU UK
| | - Kate Radford
- Ageing and Disability Research Unit, Queen’s Medical Centre, University of Nottingham, Nottingham, NG7 2UH UK
| | - June Culley
- Derby National Rheumatoid Arthritis Society branch, Derby, UK
| | - Diane Whitham
- Nottingham Clinical Trials Unit, Queens Medical Centre, University of Nottingham, NG7 2UHL, Nottingham, UK
| | | |
Collapse
|
33
|
Personal and Workplace Environmental Factors Associated With Reduced Worker Productivity Among Older Workers With Chronic Knee Pain: A Cross-Sectional Survey. J Occup Environ Med 2017. [PMID: 28628054 DOI: 10.1097/jom.0000000000001000] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVES The aim of this study was to explore personal and workplace environmental factors as predictors of reduced worker productivity among older workers with chronic knee pain. METHODS A questionnaire-based survey was conducted among 129 older workers who had participated in a randomized clinical trial evaluating dietary supplements. Multivariable analyses were used to explore predictors of reduced work productivity among older workers with chronic knee pain. RESULTS The likelihood of presenteeism was higher in those reporting knee pain (≥3/10) or problems with other joints, and lower in those reporting job insecurity. The likelihood of work transitions was higher in people reporting knee pain (≥3/10), a high comorbidity score or low coworker support, and lower in those having an occupation involving sitting more than 30% of the day. CONCLUSION Allowing access to sitting and promoting positive affiliations between coworkers are likely to provide an enabling workplace environment for older workers with chronic knee pain.
Collapse
|
34
|
Pahlplatz TMJ, Schafroth MU, Kuijer PPFM. Patient-related and work-related factors play an important role in return to work after total knee arthroplasty: a systematic review. J ISAKOS 2017. [DOI: 10.1136/jisakos-2016-000088] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
35
|
Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations. Pain 2017; 157:1836-1850. [PMID: 27058676 DOI: 10.1097/j.pain.0000000000000577] [Citation(s) in RCA: 141] [Impact Index Per Article: 17.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Although pain reduction is commonly the primary outcome in chronic pain clinical trials, physical functioning is also important. A challenge in designing chronic pain trials to determine efficacy and effectiveness of therapies is obtaining appropriate information about the impact of an intervention on physical function. The Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) and Outcome Measures in Rheumatology (OMERACT) convened a meeting to consider assessment of physical functioning and participation in research on chronic pain. The primary purpose of this article is to synthesize evidence on the scope of physical functioning to inform work on refining physical function outcome measurement. We address issues in assessing this broad construct and provide examples of frequently used measures of relevant concepts. Investigators can assess physical functioning using patient-reported outcome (PRO), performance-based, and objective measures of activity. This article aims to provide support for the use of these measures, covering broad aspects of functioning, including work participation, social participation, and caregiver burden, which researchers should consider when designing chronic pain clinical trials. Investigators should consider the inclusion of both PROs and performance-based measures as they provide different but also important complementary information. The development and use of reliable and valid PROs and performance-based measures of physical functioning may expedite development of treatments, and standardization of these measures has the potential to facilitate comparison across studies. We provide recommendations regarding important domains to stimulate research to develop tools that are more robust, address consistency and standardization, and engage patients early in tool development.
Collapse
|
36
|
Systematic Review of Health-Related Work Outcome Measures and Quality Criteria-Based Evaluations of Their Psychometric Properties. Arch Phys Med Rehabil 2017; 98:534-560. [DOI: 10.1016/j.apmr.2016.06.013] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2016] [Revised: 06/14/2016] [Accepted: 06/22/2016] [Indexed: 01/12/2023]
|
37
|
Rotondi NK, Beaton DE, Ilieff M, Adhihetty C, Linton D, Bogoch E, Sale J, Hogg-Johnson S, Jaglal S, Jain R, Weldon J. The impact of fragility fractures on work and characteristics associated with time to return to work. Osteoporos Int 2017; 28:349-358. [PMID: 27492487 DOI: 10.1007/s00198-016-3730-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/12/2016] [Accepted: 07/29/2016] [Indexed: 11/30/2022]
Abstract
UNLABELLED We examined the impact of fragility fractures on the work outcomes of employed patients. The majority successfully returned to their previous jobs in a short amount of time, and productivity loss at work was low. Our findings underscore the fast recovery rates of working fragility fracture patients. INTRODUCTION The purpose of this study is to describe the impact of fragility fractures on the work outcomes of patients who were employed at the time of their fracture. METHODS A self-report anonymous survey was mailed to fragility fracture patients over 50 who were screened as part of the quality assurance programs of fracture clinics across 35 hospitals in Ontario, Canada. Measures of return to work (RTW), at-work productivity loss (Work Limitations Questionnaire), and sociodemographic, fracture-related, and job characteristics were included in the survey. Kaplan-Meier estimates of the cumulative proportion of patients still off work were computed. Factors associated with RTW time following a fragility fracture were examined using Cox proportional hazards modeling. RESULTS Of 275 participants, 242 (88 %) returned to work. Of these, the median RTW time was 20.5 days. About 86 % returned to the same job, duties, and hours as before their injury. Among full-time workers, the median number of lost hours due to presenteeism was 2.9 h (Q1-Q3 0.4-8.1 h). The median cost of presenteeism was $75.30 based on the month prior to survey completion. In multivariable analyses, female gender, needing surgery, and medium/heavy work requirements were associated with longer RTW time. Earlier RTW time was associated with elbow fracture and feeling completely better at time of survey completion. CONCLUSIONS The majority of fragility fracture patients successfully returned to their previous jobs in a short amount of time, and productivity loss at work was low. Our findings underscore their fast recovery rates and give reason for optimism regarding the resilience of this population.
Collapse
Affiliation(s)
- N K Rotondi
- Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, 30 Bond St., Toronto, Ontario, M5B 1W8, Canada.
| | - D E Beaton
- Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, 30 Bond St., Toronto, Ontario, M5B 1W8, Canada
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
- Institute for Work & Health, University of Toronto, Toronto, Ontario, Canada
| | - M Ilieff
- Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, 30 Bond St., Toronto, Ontario, M5B 1W8, Canada
- Department of Psychology, Ryerson University, Toronto, Ontario, Canada
| | - C Adhihetty
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
| | - D Linton
- Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, 30 Bond St., Toronto, Ontario, M5B 1W8, Canada
| | - E Bogoch
- Mobility Program, St. Michael's Hospital, Toronto, Ontario, Canada
- Department of Surgery, University of Toronto, Toronto, Ontario, Canada
| | - J Sale
- Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, 30 Bond St., Toronto, Ontario, M5B 1W8, Canada
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
| | - S Hogg-Johnson
- Institute for Work & Health, University of Toronto, Toronto, Ontario, Canada
| | - S Jaglal
- Toronto Rehabilitation Institute, Toronto, Ontario, Canada
- Department of Physical Therapy, University of Toronto, Toronto, Ontario, Canada
| | - R Jain
- Osteoporosis Canada, Toronto, Ontario, Canada
| | - J Weldon
- Osteoporosis Canada, Toronto, Ontario, Canada
| |
Collapse
|
38
|
Alheresh R, Vaughan M, LaValley MP, Coster W, Keysor JJ. Critical Appraisal of the Quality of Literature Evaluating Psychometric Properties of Arthritis Work Outcome Assessments: A Systematic Review. Arthritis Care Res (Hoboken) 2016; 68:1354-70. [PMID: 26679938 DOI: 10.1002/acr.22814] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2015] [Revised: 12/04/2015] [Accepted: 12/08/2015] [Indexed: 11/11/2022]
Abstract
OBJECTIVE To systematically rate the evidence on the measurement properties of work functioning instruments for people with arthritis and other rheumatologic conditions. METHODS A systematic review was conducted through a structured search to identify the quality of articles describing studies of assessment development and studies of their psychometric properties. The Consensus-Based Standards for the Selection of Health Measurement Instruments (COSMIN) checklist was used to appraise the included studies. Finally, an evidence synthesis was performed to combine findings. RESULTS Nine arthritis-specific work outcome assessments were identified; 17 articles examining the psychometric properties of these instruments were identified and their quality was reviewed. Quality of studies was highly variable. The evidence synthesis showed that the Work Limitations Questionnaire had the strongest quality evidence of internal consistency and content validity (including structural validity and hypothesis testing), followed by the Work Instability Scale. None of the instruments had strong quality evidence of criterion validity or responsiveness. CONCLUSION Considering the high variability and the low quality of the literature, we recommend that instrument developers integrate a full psychometric assessment of their instruments, including responsiveness and criterion validity, and consult guidelines (i.e., COSMIN) in reporting their findings.
Collapse
|
39
|
Vänni K, Neupane S, Nygård CH. An effort to assess the relation between productivity loss costs and presenteeism at work. INTERNATIONAL JOURNAL OF OCCUPATIONAL SAFETY AND ERGONOMICS 2016; 23:33-43. [DOI: 10.1080/10803548.2016.1197578] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
40
|
Jetha A, Badley E, Beaton D, Fortin PR, Shiff NJ, Gignac MAM. Unpacking Early Work Experiences of Young Adults With Rheumatic Disease: An Examination of Absenteeism, Job Disruptions, and Productivity Loss. Arthritis Care Res (Hoboken) 2016; 67:1246-1254. [PMID: 25892130 DOI: 10.1002/acr.22601] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2015] [Revised: 03/09/2015] [Accepted: 04/14/2015] [Indexed: 11/09/2022]
Abstract
OBJECTIVE To examine work absenteeism, job disruptions, and perceived productivity loss and factors associated with each outcome in young adults living with systemic lupus erythematosus (SLE) and juvenile arthritis (JA). METHODS One hundred forty-three young adults, ages 18-30 years with SLE (54.5%) and JA (45.5%), completed an online survey of work experiences. Demographic, health (e.g., fatigue, disease activity), psychosocial (e.g., independence, social support), and work context (e.g., career satisfaction, job control, self-disclosure) information was collected. Participants were asked about absenteeism, job disruptions, and perceived productivity loss in the last 6 months. Log Poisson regression analyses examined factors associated with work outcomes. RESULTS A majority of participants (59%) were employed and reported a well-managed health condition. Employed respondents were satisfied with their career progress and indicated moderate job control. More than 40% of participants reported absenteeism, job disruptions, and productivity loss. Greater job control and self-disclosure, and less social support, were related to a higher likelihood of absenteeism. More disease activity was related to a greater likelihood of reporting job disruptions. Lower fatigue and higher job control were associated with a reduced likelihood of a productivity loss. CONCLUSION Young adult respondents with rheumatic disease experienced challenges with employment, including absenteeism, job disruptions, and productivity loss. While related to greater absenteeism, job control could play a role in a young person's ability to manage their health condition and sustain productive employment. Greater attention should also be paid to understanding health factors and social support in early work experiences.
Collapse
Affiliation(s)
- Arif Jetha
- Dalla Lana School of Public Health, University of Toronto, and Toronto Western Research Institute, Toronto, Ontario, Canada
| | - Elizabeth Badley
- Dalla Lana School of Public Health, University of Toronto, and Toronto Western Research Institute, Toronto, Ontario, Canada
| | - Dorcas Beaton
- Institute for Work and Health and St. Michaels Hospital, Toronto, Ontario, Canada
| | - Paul R Fortin
- Centre Hospitalier Universitaire de Québec and Faculté de Médecine de L'Université Laval, Quebec City, Quebec, Canada
| | | | - Monique A M Gignac
- Dalla Lana School of Public Health, University of Toronto, Toronto Western Research Institute, and Institute for Work and Health, Toronto, Ontario, Canada
| |
Collapse
|
41
|
Gardner BT, Dale AM, Buckner-Petty S, Rachford R, Strickland J, Kaskutas V, Evanoff B. Functional Measures Developed for Clinical Populations Identified Impairment Among Active Workers with Upper Extremity Disorders. JOURNAL OF OCCUPATIONAL REHABILITATION 2016; 26:84-94. [PMID: 26091980 PMCID: PMC5301801 DOI: 10.1007/s10926-015-9591-4] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
PURPOSE Few studies have explored measures of function across a range of health outcomes in a general working population. Using four upper extremity (UE) case definitions from the scientific literature, we described the performance of functional measures of work, activities of daily living, and overall health. METHODS A sample of 573 workers completed several functional measures: modified recall versions of the QuickDASH, Levine Functional Status Scale (FSS), DASH Work module (DASH-W), and standard SF-8 physical component score. We determined case status based on four UE case definitions: (1) UE symptoms, (2) UE musculoskeletal disorders (MSD), (3) carpal tunnel syndrome (CTS), and (4) work limitations due to UE symptoms. We calculated effect sizes for each case definition to show the magnitude of the differences that were detected between cases and non-cases for each case definition on each functional measure. Sensitivity and specificity analyses showed how well each measure identified functional impairments across the UE case definitions. RESULTS All measures discriminated between cases and non-cases for each case definition with the largest effect sizes for CTS and work limitations, particularly for the modified FSS and DASH-W measures. Specificity was high and sensitivity was low for outcomes of UE symptoms and UE MSD in all measures. Sensitivity was high for CTS and work limitations. CONCLUSIONS Functional measures developed specifically for use in clinical, treatment-seeking populations may identify mild levels of impairment in relatively healthy, active working populations, but measures performed better among workers with CTS or those reporting limitations at work.
Collapse
Affiliation(s)
- Bethany T Gardner
- Division of General Medical Sciences, Washington University School of Medicine, Campus Box 8005, 660 S. Euclid Avenue, Saint Louis, MO, 63110, USA
| | - Ann Marie Dale
- Division of General Medical Sciences, Washington University School of Medicine, Campus Box 8005, 660 S. Euclid Avenue, Saint Louis, MO, 63110, USA.
| | - Skye Buckner-Petty
- Division of General Medical Sciences, Washington University School of Medicine, Campus Box 8005, 660 S. Euclid Avenue, Saint Louis, MO, 63110, USA
| | - Robert Rachford
- Division of General Medical Sciences, Washington University School of Medicine, Campus Box 8005, 660 S. Euclid Avenue, Saint Louis, MO, 63110, USA
| | - Jaime Strickland
- Division of General Medical Sciences, Washington University School of Medicine, Campus Box 8005, 660 S. Euclid Avenue, Saint Louis, MO, 63110, USA
| | - Vicki Kaskutas
- Division of General Medical Sciences, Washington University School of Medicine, Campus Box 8005, 660 S. Euclid Avenue, Saint Louis, MO, 63110, USA
- Program in Occupational Therapy, Washington University School of Medicine, Campus Box 8505, 4444 Forest Park Avenue, Saint Louis, MO, 63108, USA
| | - Bradley Evanoff
- Division of General Medical Sciences, Washington University School of Medicine, Campus Box 8005, 660 S. Euclid Avenue, Saint Louis, MO, 63110, USA
| |
Collapse
|
42
|
Gardner BT, Dale AM, Buckner-Petty S, Van Dillen L, Amick BC, Evanoff B. Comparison of Employer Productivity Metrics to Lost Productivity Estimated by Commonly Used Questionnaires. J Occup Environ Med 2016; 58:170-7. [PMID: 26849261 PMCID: PMC5009902 DOI: 10.1097/jom.0000000000000587] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
OBJECTIVE The aim of the study was to assess construct and discriminant validity of four health-related work productivity loss questionnaires in relation to employer productivity metrics, and to describe variation in economic estimates of productivity loss provided by the questionnaires in healthy workers. METHODS Fifty-eight billing office workers completed surveys including health information and four productivity loss questionnaires. Employer productivity metrics and work hours were also obtained. RESULTS Productivity loss questionnaires were weakly to moderately correlated with employer productivity metrics. Workers with more health complaints reported greater health-related productivity loss than healthier workers, but showed no loss on employer productivity metrics. Economic estimates of productivity loss showed wide variation among questionnaires, yet no loss of actual productivity. CONCLUSIONS Additional studies are needed comparing questionnaires with objective measures in larger samples and other industries, to improve measurement methods for health-related productivity loss.
Collapse
Affiliation(s)
- Bethany T Gardner
- Division of General Medical Sciences (Dr Gardner, Dr Dale, Ms Buckner-Petty, Dr Evanoff); Program in Physical Therapy (Dr Van Dillen), Washington University School of Medicine, St Louis, MO; and Department of Health Policy and Management (Dr Amick), Robert Stempel College of Public Health & Social Work, Florida International University, Miami
| | | | | | | | | | | |
Collapse
|
43
|
Leggett S, van der Zee-Neuen A, Boonen A, Beaton D, Bojinca M, Bosworth A, Dadoun S, Fautrel B, Hagel S, Hofstetter C, Lacaille D, Linton D, Mihai C, Petersson IF, Rogers P, Sciré C, Verstappen SMM. Content validity of global measures for at-work productivity in patients with rheumatic diseases: an international qualitative study. Rheumatology (Oxford) 2016; 55:1364-73. [PMID: 26796771 DOI: 10.1093/rheumatology/kev435] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2015] [Indexed: 01/18/2023] Open
Abstract
OBJECTIVES To identify from a patient's perspective, difficulties and differences in the comprehension of five global presenteeism measures in patients with inflammatory arthritis and OA across seven countries. METHODS Seventy patients with a diagnosis of inflammatory arthritis or OA in paid employment were recruited from seven countries across Europe and Canada. Patients were randomly allocated to be cognitively debriefed on 3/5 global measures [Work Productivity Scale - Rheumatoid Arthritis, Work Productivity and Activity Impairment Questionnaire (WPAI), Work Ability Index, Quality and Quantity questionnaire, and WHO Health and Work Performance Questionnaire (HPQ)], with the WPAI debriefed in all patients as a standard measure of comparison between countries and patients. NVivo was used to code the data into four themes: construct and anchor, time recall, reference frame, and attribution. RESULTS Discrepancies were found in the interpretation of the word performance (HPQ) between countries, with Romania and Sweden relating performance to sports rather than work. Seventy percent of patients considered that a 7-day recall (WPAI) can accurately represent how their disease affects work productivity. The compared to normal reference (Quality and Quantity questionnaire) was reportedly too ambiguous, and the comparison with colleagues (HPQ), made many feel uncomfortable. Overall, 29% of patients said the WPAI was the most relevant to them, making it the most favoured measure. CONCLUSION Overall, patients across countries agree that the construct of work productivity in the last 7 days can accurately reflect the impact of disease while at work. Some current constructs to assess at-work productivity are not interchangeable between languages.
Collapse
Affiliation(s)
- Sarah Leggett
- Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK,
| | - Antje van der Zee-Neuen
- Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, Maastricht, the Netherlands
| | - Annelies Boonen
- Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, Maastricht, the Netherlands
| | - Dorcas Beaton
- Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, ON, Canada
| | - Mihai Bojinca
- Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
| | | | - Sabrina Dadoun
- Department of Rheumatology, Université Pierre et Marie Curie, Paris, France
| | - Bruno Fautrel
- Department of Rheumatology, Université Pierre et Marie Curie, Paris, France
| | - Sofia Hagel
- Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden
| | | | - Diane Lacaille
- Arthritis Research Centre of Canada, University of British Columbia, Vancouver, BC, Canada
| | - Denise Linton
- Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, ON, Canada
| | - Carina Mihai
- Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
| | | | - Pam Rogers
- Arthritis Research Centre of Canada, University of British Columbia, Vancouver, BC, Canada
| | - Carlo Sciré
- Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy and
| | - Suzanne M M Verstappen
- Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK, Arthritis Research UK/MRC Centre for Work and Health, University of Southampton, Southampton, UK
| | | |
Collapse
|
44
|
Gilworth G, Smyth MG, Smith J, Tennant A. The Manual Work Instability Scale: development and validation. Occup Med (Lond) 2016; 66:300-4. [PMID: 26747888 DOI: 10.1093/occmed/kqv217] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND Increasing awareness of the burden of absenteeism and reduced performance at work highlights the importance of early identification of individuals experiencing work instability (WI), a mismatch between functional and cognitive abilities and job demands. AIMS To develop and validate a screening questionnaire to measure WI in manual workers. METHODS Questionnaire items were generated via qualitative interviews with manual workers and a draft survey instrument was completed by workers in a variety of fields. Rasch analysis was used interactively to assess the psychometric aspects of the emerging scale, including unidimensionality and absence of item bias (differential item functioning). RESULTS A total of 17 qualitative interviews generated 110 potential items for the questionnaire. The item set resolved to a 25-item scale, which satisfied model expectations (item residual mean = -0.13, SD = 1.04; person residual mean = -0.29, SD = 0.75), had good reliability (alpha = 0.86) and strict unidimensionality (t-test 7.5% confidence interval 3.8-11.2). CONCLUSIONS The Manual Work Instability Scale is a short psychometrically robust questionnaire based on the concept of WI, which incorporates both musculoskeletal symptoms and relevant psychosocial factors. It may prove effective in screening and identifying WI in workers in predominantly physical occupations.
Collapse
Affiliation(s)
- G Gilworth
- Department of Rehabilitation Medicine, Faculty of Medicine and Health, The University of Leeds, D Floor, Martin Wing, The General Infirmary at Leeds, Gt. George Street, Leeds, West Yorkshire LS1 3EX, UK
| | - M G Smyth
- Work Fit Occupational Physiotherapy and Ergonomics Services Ltd., 38 Newlay Lane, Leeds, West Yorkshire LS18 4LE, UK
| | - J Smith
- Work Fit Occupational Physiotherapy and Ergonomics Services Ltd., 38 Newlay Lane, Leeds, West Yorkshire LS18 4LE, UK
| | - A Tennant
- Schweizer Paraplegiker-Forschung AG, Guido A. Zäch Strasse 4, 6207 Nottwil, Switzerland.
| |
Collapse
|
45
|
Leggett S, van der Zee-Neuen A, Boonen A, Beaton DE, Bojinca M, Bosworth A, Dadoun S, Fautrel B, Hagel S, Hofstetter C, Lacaille D, Linton D, Mihai C, Petersson IF, Rogers P, Sergeant JC, Sciré C, Verstappen SMM. Test-retest Reliability and Correlations of 5 Global Measures Addressing At-work Productivity Loss in Patients with Rheumatic Diseases. J Rheumatol 2015; 43:433-9. [PMID: 26628608 DOI: 10.3899/jrheum.141605] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/01/2015] [Indexed: 01/23/2023]
Abstract
OBJECTIVE Several global measures to assess at-work productivity loss or presenteeism in patients with rheumatic diseases have been proposed, but the comparative validity is hampered by the lack of data on test-retest reliability and comparative concurrent and construct validity. Our objective was to test-retest 5 global measures of presenteeism and to compare the association between these scales and health-related well-being. METHODS Sixty-five participants with inflammatory arthritis or osteoarthritis in paid employment were recruited from 7 countries (UK, Canada, Netherlands, France, Sweden, Romania, and Italy). At baseline and 2 weeks later, 5 global measures of presenteeism were evaluated: the Work Productivity Scale-Rheumatoid Arthritis (WPS-RA), Work Productivity and Activity Impairment Questionnaire (WPAI), Work Ability Index (WAI), Quality and Quantity questionnaire (QQ), and the WHO Health and Performance Questionnaire (HPQ). Agreement between the 2 timepoints was assessed using single-measure intraclass correlations (ICC) and correlated between each other and with visual analog scale general well-being scores at followup by Spearman correlation. RESULTS ICC between measures ranged from fair (HPQ 0.59) to excellent (WPS-RA 0.78). Spearman correlations between measures were moderate (Qquality vs WAI, r = 0.51) to strong (WPS-RA vs WPAI, r = 0.88). Correlations between measures and general well-being were low to moderate, ranging from -0.44 ≤ r ≤ 0.66. CONCLUSION Test-retest results of 4 out of 5 global measures were good, and the correlations between these were moderate. The latter probably reflect differences in the concepts, recall periods, and references used in the measures, which implies that some measures are probably not interchangeable.
Collapse
Affiliation(s)
- Sarah Leggett
- From the Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, The Netherlands; Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Rheumatoid Arthritis Society, Maidenhead, UK; Department of Rheumatology, Université Pierre et Marie Curie, Paris, France; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada; Arthritis Research Centre of Canada, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada; Orthopaedics, Clinical Sciences Lund, Lund University, Lund, Sweden; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; and the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Research, University of Southampton, Southampton, UK.S. Leggett, MSc, Arthritis Research UK Centre for Epidemiology; A. van der Zee-Neuen, PhD, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; A. Boonen, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; D.E. Beaton, PhD, Mobility Program Clinical Research Unit, St. Michael's Hospital; M. Bojinca, MD, PhD, Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy; A. Bosworth, Patient Partner, National Rheumatoid A
| | - Antje van der Zee-Neuen
- From the Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, The Netherlands; Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Rheumatoid Arthritis Society, Maidenhead, UK; Department of Rheumatology, Université Pierre et Marie Curie, Paris, France; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada; Arthritis Research Centre of Canada, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada; Orthopaedics, Clinical Sciences Lund, Lund University, Lund, Sweden; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; and the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Research, University of Southampton, Southampton, UK.S. Leggett, MSc, Arthritis Research UK Centre for Epidemiology; A. van der Zee-Neuen, PhD, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; A. Boonen, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; D.E. Beaton, PhD, Mobility Program Clinical Research Unit, St. Michael's Hospital; M. Bojinca, MD, PhD, Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy; A. Bosworth, Patient Partner, National Rheumatoid A
| | - Annelies Boonen
- From the Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, The Netherlands; Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Rheumatoid Arthritis Society, Maidenhead, UK; Department of Rheumatology, Université Pierre et Marie Curie, Paris, France; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada; Arthritis Research Centre of Canada, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada; Orthopaedics, Clinical Sciences Lund, Lund University, Lund, Sweden; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; and the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Research, University of Southampton, Southampton, UK.S. Leggett, MSc, Arthritis Research UK Centre for Epidemiology; A. van der Zee-Neuen, PhD, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; A. Boonen, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; D.E. Beaton, PhD, Mobility Program Clinical Research Unit, St. Michael's Hospital; M. Bojinca, MD, PhD, Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy; A. Bosworth, Patient Partner, National Rheumatoid A
| | - Dorcas E Beaton
- From the Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, The Netherlands; Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Rheumatoid Arthritis Society, Maidenhead, UK; Department of Rheumatology, Université Pierre et Marie Curie, Paris, France; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada; Arthritis Research Centre of Canada, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada; Orthopaedics, Clinical Sciences Lund, Lund University, Lund, Sweden; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; and the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Research, University of Southampton, Southampton, UK.S. Leggett, MSc, Arthritis Research UK Centre for Epidemiology; A. van der Zee-Neuen, PhD, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; A. Boonen, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; D.E. Beaton, PhD, Mobility Program Clinical Research Unit, St. Michael's Hospital; M. Bojinca, MD, PhD, Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy; A. Bosworth, Patient Partner, National Rheumatoid A
| | - Mihai Bojinca
- From the Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, The Netherlands; Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Rheumatoid Arthritis Society, Maidenhead, UK; Department of Rheumatology, Université Pierre et Marie Curie, Paris, France; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada; Arthritis Research Centre of Canada, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada; Orthopaedics, Clinical Sciences Lund, Lund University, Lund, Sweden; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; and the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Research, University of Southampton, Southampton, UK.S. Leggett, MSc, Arthritis Research UK Centre for Epidemiology; A. van der Zee-Neuen, PhD, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; A. Boonen, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; D.E. Beaton, PhD, Mobility Program Clinical Research Unit, St. Michael's Hospital; M. Bojinca, MD, PhD, Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy; A. Bosworth, Patient Partner, National Rheumatoid A
| | - Ailsa Bosworth
- From the Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, The Netherlands; Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Rheumatoid Arthritis Society, Maidenhead, UK; Department of Rheumatology, Université Pierre et Marie Curie, Paris, France; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada; Arthritis Research Centre of Canada, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada; Orthopaedics, Clinical Sciences Lund, Lund University, Lund, Sweden; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; and the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Research, University of Southampton, Southampton, UK.S. Leggett, MSc, Arthritis Research UK Centre for Epidemiology; A. van der Zee-Neuen, PhD, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; A. Boonen, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; D.E. Beaton, PhD, Mobility Program Clinical Research Unit, St. Michael's Hospital; M. Bojinca, MD, PhD, Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy; A. Bosworth, Patient Partner, National Rheumatoid A
| | - Sabrina Dadoun
- From the Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, The Netherlands; Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Rheumatoid Arthritis Society, Maidenhead, UK; Department of Rheumatology, Université Pierre et Marie Curie, Paris, France; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada; Arthritis Research Centre of Canada, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada; Orthopaedics, Clinical Sciences Lund, Lund University, Lund, Sweden; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; and the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Research, University of Southampton, Southampton, UK.S. Leggett, MSc, Arthritis Research UK Centre for Epidemiology; A. van der Zee-Neuen, PhD, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; A. Boonen, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; D.E. Beaton, PhD, Mobility Program Clinical Research Unit, St. Michael's Hospital; M. Bojinca, MD, PhD, Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy; A. Bosworth, Patient Partner, National Rheumatoid A
| | - Bruno Fautrel
- From the Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, The Netherlands; Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Rheumatoid Arthritis Society, Maidenhead, UK; Department of Rheumatology, Université Pierre et Marie Curie, Paris, France; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada; Arthritis Research Centre of Canada, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada; Orthopaedics, Clinical Sciences Lund, Lund University, Lund, Sweden; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; and the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Research, University of Southampton, Southampton, UK.S. Leggett, MSc, Arthritis Research UK Centre for Epidemiology; A. van der Zee-Neuen, PhD, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; A. Boonen, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; D.E. Beaton, PhD, Mobility Program Clinical Research Unit, St. Michael's Hospital; M. Bojinca, MD, PhD, Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy; A. Bosworth, Patient Partner, National Rheumatoid A
| | - Sofia Hagel
- From the Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, The Netherlands; Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Rheumatoid Arthritis Society, Maidenhead, UK; Department of Rheumatology, Université Pierre et Marie Curie, Paris, France; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada; Arthritis Research Centre of Canada, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada; Orthopaedics, Clinical Sciences Lund, Lund University, Lund, Sweden; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; and the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Research, University of Southampton, Southampton, UK.S. Leggett, MSc, Arthritis Research UK Centre for Epidemiology; A. van der Zee-Neuen, PhD, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; A. Boonen, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; D.E. Beaton, PhD, Mobility Program Clinical Research Unit, St. Michael's Hospital; M. Bojinca, MD, PhD, Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy; A. Bosworth, Patient Partner, National Rheumatoid A
| | - Catherine Hofstetter
- From the Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, The Netherlands; Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Rheumatoid Arthritis Society, Maidenhead, UK; Department of Rheumatology, Université Pierre et Marie Curie, Paris, France; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada; Arthritis Research Centre of Canada, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada; Orthopaedics, Clinical Sciences Lund, Lund University, Lund, Sweden; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; and the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Research, University of Southampton, Southampton, UK.S. Leggett, MSc, Arthritis Research UK Centre for Epidemiology; A. van der Zee-Neuen, PhD, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; A. Boonen, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; D.E. Beaton, PhD, Mobility Program Clinical Research Unit, St. Michael's Hospital; M. Bojinca, MD, PhD, Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy; A. Bosworth, Patient Partner, National Rheumatoid A
| | - Diane Lacaille
- From the Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, The Netherlands; Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Rheumatoid Arthritis Society, Maidenhead, UK; Department of Rheumatology, Université Pierre et Marie Curie, Paris, France; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada; Arthritis Research Centre of Canada, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada; Orthopaedics, Clinical Sciences Lund, Lund University, Lund, Sweden; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; and the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Research, University of Southampton, Southampton, UK.S. Leggett, MSc, Arthritis Research UK Centre for Epidemiology; A. van der Zee-Neuen, PhD, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; A. Boonen, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; D.E. Beaton, PhD, Mobility Program Clinical Research Unit, St. Michael's Hospital; M. Bojinca, MD, PhD, Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy; A. Bosworth, Patient Partner, National Rheumatoid A
| | - Denise Linton
- From the Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, The Netherlands; Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Rheumatoid Arthritis Society, Maidenhead, UK; Department of Rheumatology, Université Pierre et Marie Curie, Paris, France; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada; Arthritis Research Centre of Canada, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada; Orthopaedics, Clinical Sciences Lund, Lund University, Lund, Sweden; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; and the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Research, University of Southampton, Southampton, UK.S. Leggett, MSc, Arthritis Research UK Centre for Epidemiology; A. van der Zee-Neuen, PhD, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; A. Boonen, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; D.E. Beaton, PhD, Mobility Program Clinical Research Unit, St. Michael's Hospital; M. Bojinca, MD, PhD, Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy; A. Bosworth, Patient Partner, National Rheumatoid A
| | - Carina Mihai
- From the Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, The Netherlands; Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Rheumatoid Arthritis Society, Maidenhead, UK; Department of Rheumatology, Université Pierre et Marie Curie, Paris, France; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada; Arthritis Research Centre of Canada, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada; Orthopaedics, Clinical Sciences Lund, Lund University, Lund, Sweden; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; and the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Research, University of Southampton, Southampton, UK.S. Leggett, MSc, Arthritis Research UK Centre for Epidemiology; A. van der Zee-Neuen, PhD, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; A. Boonen, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; D.E. Beaton, PhD, Mobility Program Clinical Research Unit, St. Michael's Hospital; M. Bojinca, MD, PhD, Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy; A. Bosworth, Patient Partner, National Rheumatoid A
| | - Ingemar F Petersson
- From the Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, The Netherlands; Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Rheumatoid Arthritis Society, Maidenhead, UK; Department of Rheumatology, Université Pierre et Marie Curie, Paris, France; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada; Arthritis Research Centre of Canada, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada; Orthopaedics, Clinical Sciences Lund, Lund University, Lund, Sweden; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; and the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Research, University of Southampton, Southampton, UK.S. Leggett, MSc, Arthritis Research UK Centre for Epidemiology; A. van der Zee-Neuen, PhD, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; A. Boonen, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; D.E. Beaton, PhD, Mobility Program Clinical Research Unit, St. Michael's Hospital; M. Bojinca, MD, PhD, Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy; A. Bosworth, Patient Partner, National Rheumatoid A
| | - Pam Rogers
- From the Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, The Netherlands; Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Rheumatoid Arthritis Society, Maidenhead, UK; Department of Rheumatology, Université Pierre et Marie Curie, Paris, France; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada; Arthritis Research Centre of Canada, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada; Orthopaedics, Clinical Sciences Lund, Lund University, Lund, Sweden; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; and the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Research, University of Southampton, Southampton, UK.S. Leggett, MSc, Arthritis Research UK Centre for Epidemiology; A. van der Zee-Neuen, PhD, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; A. Boonen, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; D.E. Beaton, PhD, Mobility Program Clinical Research Unit, St. Michael's Hospital; M. Bojinca, MD, PhD, Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy; A. Bosworth, Patient Partner, National Rheumatoid A
| | - Jamie C Sergeant
- From the Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, The Netherlands; Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Rheumatoid Arthritis Society, Maidenhead, UK; Department of Rheumatology, Université Pierre et Marie Curie, Paris, France; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada; Arthritis Research Centre of Canada, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada; Orthopaedics, Clinical Sciences Lund, Lund University, Lund, Sweden; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; and the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Research, University of Southampton, Southampton, UK.S. Leggett, MSc, Arthritis Research UK Centre for Epidemiology; A. van der Zee-Neuen, PhD, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; A. Boonen, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; D.E. Beaton, PhD, Mobility Program Clinical Research Unit, St. Michael's Hospital; M. Bojinca, MD, PhD, Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy; A. Bosworth, Patient Partner, National Rheumatoid A
| | - Carlo Sciré
- From the Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, The Netherlands; Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Rheumatoid Arthritis Society, Maidenhead, UK; Department of Rheumatology, Université Pierre et Marie Curie, Paris, France; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada; Arthritis Research Centre of Canada, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada; Orthopaedics, Clinical Sciences Lund, Lund University, Lund, Sweden; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; and the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Research, University of Southampton, Southampton, UK.S. Leggett, MSc, Arthritis Research UK Centre for Epidemiology; A. van der Zee-Neuen, PhD, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; A. Boonen, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; D.E. Beaton, PhD, Mobility Program Clinical Research Unit, St. Michael's Hospital; M. Bojinca, MD, PhD, Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy; A. Bosworth, Patient Partner, National Rheumatoid A
| | - Suzanne M M Verstappen
- From the Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute, Maastricht University, The Netherlands; Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Rheumatoid Arthritis Society, Maidenhead, UK; Department of Rheumatology, Université Pierre et Marie Curie, Paris, France; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skane University Hospital, Lund, Sweden; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada; Arthritis Research Centre of Canada, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada; Orthopaedics, Clinical Sciences Lund, Lund University, Lund, Sweden; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; and the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Research, University of Southampton, Southampton, UK.S. Leggett, MSc, Arthritis Research UK Centre for Epidemiology; A. van der Zee-Neuen, PhD, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; A. Boonen, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Maastricht University Medical Centre, and Caphri Research Institute; D.E. Beaton, PhD, Mobility Program Clinical Research Unit, St. Michael's Hospital; M. Bojinca, MD, PhD, Internal Medicine and Rheumatology Clinic, Dr. Ion Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy; A. Bosworth, Patient Partner, National Rheumatoid A
| | | |
Collapse
|
46
|
Revicki D, Ganguli A, Kimel M, Roy S, Chen N, Safikhani S, Cifaldi M. Reliability and Validity of the Work Instability Scale for Rheumatoid Arthritis. VALUE IN HEALTH : THE JOURNAL OF THE INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH 2015; 18:1008-1015. [PMID: 26686785 DOI: 10.1016/j.jval.2015.09.2941] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/18/2014] [Revised: 08/13/2015] [Accepted: 09/18/2015] [Indexed: 06/05/2023]
Abstract
OBJECTIVE The objective was to evaluate the psychometric properties of the Rheumatoid Arthritis-Work Instability Scale (RA-WIS) in a clinical trial setting. METHODS Secondary analyses were conducted using data from a 56-week, randomized controlled trial of patients with early rheumatoid arthritis (RA). Patient-reported outcome measures included the RA-WIS, the Health Assessment Questionnaire (HAQ), the Rheumatoid Arthritis Quality of Life Questionnaire, and the Global Assessment of Disease Activity and Pain, data for which were collected at baseline and at weeks 12, 16, 24, and 56. Data were analyzed for reliability, validity, and responsiveness. RESULTS Among 148 patients whose data were analyzed, more than half were women (56.1%) with a mean age of 46.8 years. On average, patients experienced RA symptoms for 8.7 months; the mean 28-Joint Disease Activity Score (DAS28) was 5.9, and the mean HAQ - Disability Index was 1.3. The RA-WIS demonstrated excellent internal consistency and test-retest reliability (α = 0.89 and intraclass correlation coefficient = 0.91, respectively). At baseline and week 24, moderate to strong correlations were seen between RA-WIS total scores and the HAQ, the Global Assessment of Disease Activity, and the Pain Rheumatoid Arthritis Quality of Life Questionnaire, ranging from 0.47 to 0.81 (all P < 0.0001). Mean RA-WIS total scores and work disability risk levels discriminated between clinical severity scores on the DAS28, the HAQ - Disability Index, and the Physician Global Assessment of Disease Activity (all P < 0.05). Mean baseline to week 24 RA-WIS total change scores were significantly different among American College of Rheumatology responder groups (P ≤ 0.0001) and between DAS28 remission status groups (P < 0.001). CONCLUSIONS These findings provide evidence supporting the reliability, validity, and responsiveness of the RA-WIS for evaluating work disability in patients with RA in a clinical trial setting.
Collapse
|
47
|
Marks M, Vliet Vlieland TPM, Audigé L, Herren DB, Nelissen RGHH, van den Hout WB. Healthcare costs and loss of productivity in patients with trapeziometacarpal osteoarthritis. J Hand Surg Eur Vol 2015; 40:927-34. [PMID: 25646143 DOI: 10.1177/1753193414568293] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/13/2014] [Accepted: 12/04/2014] [Indexed: 02/03/2023]
Abstract
The objective of this study was to analyse healthcare and productivity costs in patients with trapeziometacarpal osteoarthritis. We included 161 patients who received surgery or steroid injection and calculated their healthcare costs in Euro (€) over 1 year. Patients filled out the Work Productivity and Activity Impairment Questionnaire to assess loss of productivity at baseline, and after 3, and 12 months. In the surgical group, loss of productivity among employed patients first increased and then decreased (50%, 64%, and 25% at 0, 3, and 12 months). Productivity was more stable over time in the injection group (52%, 38%, and 48%). In the surgical group, estimated total annual healthcare and productivity costs were €5770 and €5548, respectively. In the injection group, healthcare and productivity costs were €348 and €3503. These findings highlight the need for assessing productivity costs to get a comprehensive view of the costs associated with a treatment.Level of Evidence III.
Collapse
Affiliation(s)
- M Marks
- Department of Research and Development, Schulthess Clinic, Zurich, Switzerland Department of Orthopaedics, Leiden University Medical Center, Leiden, The Netherlands
| | - T P M Vliet Vlieland
- Department of Orthopaedics, Leiden University Medical Center, Leiden, The Netherlands
| | - L Audigé
- Department of Research and Development, Schulthess Clinic, Zurich, Switzerland
| | - D B Herren
- Department of Hand Surgery, Schulthess Clinic, Zurich, Switzerland
| | - R G H H Nelissen
- Department of Orthopaedics, Leiden University Medical Center, Leiden, The Netherlands
| | - W B van den Hout
- Department of Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands
| |
Collapse
|
48
|
Boezeman EJ, Sluiter JK, Nieuwenhuijsen K. Measuring Work Functioning: Validity of a Weighted Composite Work Functioning Approach. JOURNAL OF OCCUPATIONAL REHABILITATION 2015; 25:537-542. [PMID: 25564439 DOI: 10.1007/s10926-014-9560-3] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
PURPOSE To examine the construct validity of a weighted composite work functioning measurement approach. METHODS Workers (health-impaired/healthy) (n = 117) completed a composite measure survey that recorded four central work functioning aspects with existing scales: capacity to work, quality of work performance, quantity of work, and recovery from work. Previous derived weights reflecting the relative importance of these aspects of work functioning were used to calculate the composite weighted work functioning score of the workers. Work role functioning, productivity, and quality of life were used for validation. Correlations were calculated and norms applied to examine convergent and divergent construct validity. A t test was conducted and a norm applied to examine discriminative construct validity. RESULTS Overall the weighted composite work functioning measure demonstrated construct validity. As predicted, the weighted composite score correlated (p < .001) strongly (r > .60) with work role functioning and productivity (convergent construct validity), and moderately (.30 < r < .60) with physical quality of life and less strongly than work role functioning and productivity with mental quality of life (divergent validity). Further, the weighted composite measure detected that health-impaired workers show with a large effect size (Cohen's d > .80) significantly worse work functioning than healthy workers (discriminative validity). CONCLUSION The weighted composite work functioning measurement approach takes into account the relative importance of the different work functioning aspects and demonstrated good convergent, fair divergent, and good discriminative construct validity.
Collapse
Affiliation(s)
- Edwin J Boezeman
- Coronel Institute of Occupational Health, Academic Medical Center, University of Amsterdam, PO Box 22700, 1100 DE, Amsterdam, The Netherlands
| | | | | |
Collapse
|
49
|
Beaton DE, Dyer S, Boonen A, Verstappen SMM, Escorpizo R, Lacaille DV, Bosworth A, Gignac MAM, Leong A, Purcaru O, Leggett S, Hofstetter C, Peterson IF, Tang K, Fautrel B, Bombardier C, Tugwell PS. OMERACT Filter Evidence Supporting the Measurement of At-work Productivity Loss as an Outcome Measure in Rheumatology Research. J Rheumatol 2015; 43:214-22. [PMID: 26329339 DOI: 10.3899/jrheum.141077] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
OBJECTIVE Indicators of work role functioning (being at work, and being productive while at work) are important outcomes for persons with arthritis. As the worker productivity working group at OMERACT (Outcome Measures in Rheumatology), we sought to provide an evidence base for consensus on standardized instruments to measure worker productivity [both absenteeism and at-work productivity (presenteeism) as well as critical contextual factors]. METHODS Literature reviews and primary studies were done and reported to the OMERACT 12 (2014) meeting to build the OMERACT Filter 2.0 evidence for worker productivity outcome measurement instruments. Contextual factor domains that could have an effect on scores on worker productivity instruments were identified by nominal group techniques, and strength of influence was further assessed by literature review. RESULTS At OMERACT 9 (2008), we identified 6 candidate measures of absenteeism, which received 94% endorsement at the plenary vote. At OMERACT 11 (2012) we received over the required minimum vote of 70% for endorsement of 2 at-work productivity loss measures. During OMERACT 12 (2014), out of 4 measures of at-work productivity loss, 3 (1 global; 2 multiitem) received support as having passed the OMERACT Filter with over 70% of the plenary vote. In addition, 3 contextual factor domains received a 95% vote to explore their validity as core contextual factors: nature of work, work accommodation, and workplace support. CONCLUSION Our current recommendations for at-work productivity loss measures are: WALS (Workplace Activity Limitations Scale), WLQ PDmod (Work Limitations Questionnaire with modified physical demands scale), WAI (Work Ability Index), WPS (Arthritis-specific Work Productivity Survey), and WPAI (Work Productivity and Activity Impairment Questionnaire). Our future research focus will shift to confirming core contextual factors to consider in the measurement of worker productivity.
Collapse
Affiliation(s)
- Dorcas E Beaton
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Sarah Dyer
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Annelies Boonen
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Suzanne M M Verstappen
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Reuben Escorpizo
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Diane V Lacaille
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Ailsa Bosworth
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Monique A M Gignac
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Amye Leong
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Oana Purcaru
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Sarah Leggett
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Cathy Hofstetter
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Ingemar F Peterson
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Kenneth Tang
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Bruno Fautrel
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Claire Bombardier
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Peter S Tugwell
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| |
Collapse
|
50
|
Dale AM, Gardner BT, Buckner-Petty S, Kaskutas V, Strickland J, Evanoff B. Responsiveness of a 1-Year Recall Modified DASH Work Module in Active Workers with Upper Extremity Musculoskeletal Symptoms. JOURNAL OF OCCUPATIONAL REHABILITATION 2015; 25:638-47. [PMID: 25636265 PMCID: PMC4521984 DOI: 10.1007/s10926-015-9571-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
OBJECTIVES To evaluate the responsiveness to change of a modified version of the Work module of the Disabilities of the Arm, Shoulder, and Hand (DASH-W) in a prospective, longitudinal cohort study of active workers. METHODS We compared change on a 1-year recall modified DASH-W to change on work ability, work productivity, and symptom severity, according to predetermined hypotheses following the Consensus-based standards for the selection of health measurement instruments (COSMIN). We evaluated concordance in the direction of change, and magnitude of change using Spearman rank correlations, effect sizes (ES), standardized response means (SRM), and area under the receiver operating characteristic curves (AUC). RESULTS In a sample of 551 workers, change in 1-year recall modified DASH-W scores showed moderate correlations with changes in work ability, work productivity, and symptom severity (r = 0.47, 0.44, and 0.36, respectively). ES and SRM were moderate for 1-year recall modified DASH-W scores in workers whose work ability (ES = -0.58, SRM = -0.52) and work productivity improved (ES = -0.59, SRM = -0.56), and larger for workers whose work ability (ES = 1.24, SRM = 0.68) and work productivity worsened (ES = 1.02, SRM = 0.61). ES and SRM were small for 1-year recall modified DASH-W scores of workers whose symptom severity improved (-0.32 and -0.29, respectively). Responsiveness of the 1-year recall modified DASH-W was moderate for those whose symptom severity worsened (ES = 0.77, SRM = 0.50). AUC met responsiveness criteria for work ability and work productivity. CONCLUSIONS The 1-year recall modified DASH-W is responsive to changes in work ability and work productivity in active workers with upper extremity symptoms.
Collapse
Affiliation(s)
- Ann Marie Dale
- Division of General Medical Sciences, Washington University School of Medicine, Campus Box 8005, 660 S. Euclid Avenue, Saint Louis, MO, 63110, USA,
| | | | | | | | | | | |
Collapse
|